Axon Regeneration	1
Hindlimb Function	46
Olfactory Ensheathing Glia Transplantation Aya Takeoka ,1 Devin L.	70
Jindrich ,1,3 Cintia Mun˜oz	137
Quiles ,4 Hui Zhong ,1 Rubia van den	164
Quiles ,4 Hui Zhong	164
,1 Rubia van den	182
Brand ,1	199
Daniel L. Pham ,1 Matthias D. Ziegler ,1 Almudena Ramo ' n-Cueto ,5 Roland	207
Daniel L. Pham ,1 Matthias D. Ziegler	207
,1 Almudena Ramo ' n-Cueto ,5 Roland	243
,1	243
Almudena Ramo ' n-Cueto ,5 Roland	246
Almudena Ramo '	246
,5	267
R. Roy	277
,1,2 V. Reggie Edgerton ,1,2 and Patricia E. Phelps1 ,2 1Department	283
Integrative Biology and Physiology	352
2Brain Research Institute	391
UCLA	418
Los Angeles	424
California 90095	437
3Department of Kinesiology	455
3Department	455
Kinesiology	470
Arizona State University	483
Tempe , Arizona 85287	509
4Fundacio 'n Investigacio	531
4Fundacio	531
Investigacio	543
Regeneracio 'n del Sistema Nervioso	561
del Sistema Nervioso	575
46019 Valencia , Spain	597
5Instituto de Biomedicina	624
Valencia , Consejo Superior de Investigaciones Científicas , 46010 Valencia ,	653
Valencia , Consejo Superior de Investigaciones Científicas	653
46010 Valencia	712
Spain Reports	728
anatomical evidence	762
olfactory ensheathing glia -LRB- OEG -RRB- transplantation	795
OEG	823
axon regeneration	853
a complete spinal cord transection in adult rats	878
a complete spinal cord transection	878
adult rats	916
functional , electrophysiological , and anatomical assessments	937
anatomical	975
we	999
OEG	1013
axon regeneration	1026
a complete spinal cord transection	1051
this regeneration	1095
altered motor responses	1113
time	1142
7 months after transection	1151
7 months	1151
transection	1166
70 % of OEG-treated rats	1179
70 %	1179
OEG-treated rats	1186
motor-evoked potentials	1210
hindlimb muscles	1237
transcranial electric stimulation	1260
a complete spinal cord retransection performed 8 months after injury	1308
a complete spinal cord retransection	1308
8 months	1355
injury	1370
this axon regeneration	1395
locomotor performance	1429
the hypersensitive hindlimb withdrawal response	1465
mechanical stimulation	1516
OEG transplantation	1540
reorganization of lumbosacral locomotor networks	1575
reorganization	1575
lumbosacral locomotor networks	1593
long-term training	1648
some stepping measures	1677
These novel findings	1701
OEG	1739
regeneration of mature axons	1751
regeneration	1751
mature axons	1767
a complete transection and reorganization	1787
spinal circuitry , both of which contribute to sensorimotor function	1832
spinal circuitry	1832
sensorimotor function	1878
Introduction Adult rodent spinal cords	1902
Introduction Adult	1902
rodent spinal cords	1921
descending connections	1985
motor output	2032
incomplete injuries -LRB- Bareyre et al. , 2004 ; Courtine et al. , 2008 -RRB-	2051
incomplete injuries	2051
Bareyre	2072
et al. , 2004 ; Courtine et al. , 2008	2080
et al.	2080
2004 ; Courtine et al.	2088
2004	2088
Courtine et al.	2094
Courtine	2094
et al.	2103
2008	2111
a complete spinal cord transection	2124
axon regeneration	2179
the lesion that contributes to functional recovery	2204
the lesion	2204
functional recovery	2235
a difficult challenge	2263
Olfactory ensheathing glia -LRB- OEG -RRB- transplantation	2286
OEG	2314
tissue sparing	2355
axon remyelination	2371
improvements	2395
motor performance	2411
incomplete and complete adult spinal cord injury -LRB- SCI -RRB- models	2432
SCI	2482
Imaizumi	2495
et al. , 1998	2504
et al.	2504
1998	2512
Ramo ' n-Cueto et al. , 2000	2518
Ramo ' n-Cueto et al.	2518
Ramo ' n-Cueto	2518
Ramo '	2518
et al.	2532
2000	2540
García-Alías et al. , 2003	2546
García-Alías	2546
et al. , 2003	2559
et al.	2559
2003	2567
Li et al. , 2003	2573
Li	2573
et al. , 2003	2576
et al.	2576
2003	2584
Fouad et al. , 2005	2590
Fouad	2590
et al. , 2005	2596
et al.	2596
2005	2604
Li et al. , 2007	2610
Li	2610
et al. , 2007	2613
et al.	2613
2007	2621
Kubasak et al. , 2008	2627
Kubasak	2627
et al. , 2008	2635
et al.	2635
2008	2643
Mun˜oz - Quiles et al. , 2009	2649
Mun˜oz	2649
Quiles et al. , 2009	2656
Quiles	2656
et al. , 2009	2663
et al.	2663
2009	2671
the results of SCI studies involving OEG transplantation	2687
the results	2687
SCI studies involving OEG transplantation	2702
SCI studies	2702
OEG transplantation	2724
the injury model	2776
the duration of the study	2794
the duration	2794
the study	2810
the source	2825
age	2837
methods	2846
the OEG -LRB- Franssen et al. , 2007 -RRB-	2885
the OEG	2885
Franssen	2894
et al. , 2007	2903
et al.	2903
2007	2911
Promising transplantation candidates that promote axon regeneration	2918
Promising transplantation candidates	2918
axon regeneration	2968
cultures	2999
olfactory bulb-derived , p75-nerve growth factor receptor	3011
NGFR	3069
positive OEG -LRB- Ramo ' n-Cueto et al. , 2000 -RRB-	3075
positive OEG	3075
Ramo ' n-Cueto et al. , 2000	3089
Ramo ' n-Cueto et al.	3089
Ramo ' n-Cueto	3089
Ramo '	3089
et al.	3103
2000	3111
these cells	3125
astrocytes	3154
the reactive astrocytic environment	3189
injury -LRB- Lakatos et al. , 2000 , 2003 -RRB-	3231
injury	3231
Lakatos	3239
et al. , 2000 , 2003	3247
et al.	3247
2000	3255
2003	3261
OEG transplantation combined with task-specific training	3268
OEG transplantation	3268
task-specific training	3302
the motor function of adult rats	3334
the motor function	3334
adult rats	3356
a complete spinal cord transection -LRB- i.e. , spinal rats -RRB-	3372
a complete spinal cord transection	3372
i.e. , spinal rats	3408
i.e.	3408
spinal rats	3414
Ramo ' n-Cueto et al.	3428
Ramo ' n-Cueto	3428
Ramo '	3428
et al.	3442
2000 ; Kubasak et al.	3450
2000	3450
Kubasak et al.	3456
Kubasak	3456
et al.	3464
2008 ; Mun˜oz - Quiles et al. , 2009	3472
2008 ; Mun˜oz	3472
2008	3472
Mun˜oz	3478
Quiles et al. , 2009	3485
Quiles	3485
et al. , 2009	3492
et al.	3492
2009	3500
we	3511
this treatment	3536
functional recovery	3560
The spinal cord	3581
locomotor activity	3626
supraspinal innervation	3653
the efficacy of locomotion -LRB- Edgerton et al. , 2004 -RRB-	3707
the efficacy	3707
locomotion -LRB- Edgerton et al. , 2004 -RRB-	3723
locomotion	3723
Edgerton	3735
et al. , 2004	3744
et al.	3744
2004	3752
example	3763
long-term step training	3772
reorganization of the lumbosacral locomotor circuitry in adult spinal cats	3805
reorganization	3805
the lumbosacral locomotor circuitry in adult spinal cats	3823
the lumbosacral locomotor circuitry	3823
adult spinal cats	3862
inhibitory neurotransmitters	3898
interneurons	3943
somatic motor neurons	3960
Edgerton	3983
et al. , 1997	3992
et al.	3992
1997	4000
de Leon et al. , 1999	4006
de Leon	4006
de	4006
Leon	4009
et al. , 1999	4014
et al.	4014
1999	4022
Tillakaratne et al. , 2000 , 2002	4028
Tillakaratne	4028
et al. , 2000 , 2002	4041
et al.	4041
2000	4049
2002	4055
Rossignol et al. , 2001	4061
Rossignol	4061
et al. , 2001	4071
et al.	4071
2001	4079
Coˆte ' and Gossard , 2003	4085
Coˆte	4085
Gossard , 2003	4096
Gossard	4096
2003	4105
motor neuron excitability in response	4128
motor neuron excitability	4128
response	4157
hindlimb loading and sensory stimulation -LRB- Coˆte ' et al. , 2003 -RRB-	4169
hindlimb loading and sensory stimulation	4169
Coˆte ' et al. , 2003	4211
Coˆte '	4211
et al.	4218
2003	4226
pharmacological or epidural electrical stimulation	4247
long-term step training	4299
the efficacy of specific sensorimotor connections	4338
the efficacy	4338
specific sensorimotor connections	4354
specific neurons	4402
locomotion -LRB- Ichiyama et al. , 2008 ; Courtine et al. , 2009 -RRB-	4426
locomotion	4426
Ichiyama	4438
et al. , 2008 ; Courtine et al. , 2009	4447
et al.	4447
2008 ; Courtine et al.	4455
2008	4455
Courtine et al.	4461
Courtine	4461
et al.	4470
2009	4478
We	4485
OEG transplantation combined with long-term step training	4506
OEG transplantation	4506
long-term step training	4540
axon regeneration	4578
the transection	4603
reorganization of the lumbosacral locomotor circuitry	4626
reorganization	4626
the lumbosacral locomotor circuitry	4644
adult spinal rats	4683
We	4702
both regeneration and reorganization	4724
the treatments	4775
functional outcomes	4804
this	4833
we	4839
sensorimotor and electrophysiological assessments	4847
8 months	4902
a complete retransection rostral	4925
the original transection 8 months	4961
the original transection	4961
8 months	4986
the initial lesion	5001
OEG transplantation	5021
functional axon regeneration	5050
the complete lesion	5086
long-term step training	5131
it	5156
reorganization of spinal locomotor networks	5171
reorganization	5171
spinal locomotor networks	5189
some of the changes in motor function	5226
some	5226
the changes in motor function	5234
the changes	5234
motor function	5249
OEG transplantation and step training point	5278
OEG transplantation	5278
step training point	5302
facilitation	5325
others	5347
suppression of sensorimotor function	5364
suppression	5364
sensorimotor function	5379
Materials and Methods OEG culture and transplantation All procedures	5403
Materials	5403
Methods OEG culture and transplantation All procedures	5417
Methods OEG culture and transplantation	5417
All procedures	5457
the National Institutes of Health guidelines	5481
the National Institutes	5481
Health guidelines	5508
the Chancellor 's Animal Research Committee	5547
the Chancellor 's	5547
UCLA	5593
Methods for OEG culture	5599
Methods	5599
OEG culture	5611
those	5641
Ramo ' n-Cueto	5650
Ramo '	5650
et al. -LRB- 2000 -RRB-	5664
et al.	5664
2000	5672
Mun˜oz - Quiles et al. -LRB- 2009 -RRB-	5682
Mun˜oz	5682
Quiles et al. -LRB- 2009 -RRB-	5689
Quiles	5689
et al. -LRB- 2009 -RRB-	5696
et al.	5696
2009	5704
OEG	5711
the outer two olfactory bulb layers of two 8	5735
the outer two olfactory bulb layers	5735
two 8	5774
10-week-old male Wistar Hannover rats -LRB- Charles River Laboratories -RRB-	5784
10-week-old male Wistar Hannover rats	5784
Charles River Laboratories	5823
transplantation	5855
one spinal rat	5876
Primary cultures	5892
p75-NGFR antibody -LRB- 1:5 -RRB- -LRB- Chandler et al. , 1984 -RRB-	5937
p75-NGFR antibody -LRB- 1:5 -RRB-	5937
p75-NGFR antibody	5937
1:5	5956
Chandler	5962
et al. , 1984	5971
et al.	5971
1984	5979
7	5988
transplantation at 14 d. Cultures -LRB- n = 10 -RRB- were 95 ± 1 %	6013
transplantation	6013
14 d. Cultures -LRB- n = 10 -RRB- were 95 ± 1 %	6032
14 d. Cultures	6032
n = 10	6048
n	6048
10	6052
95 ± 1 %	6061
95	6061
1 %	6066
S100 and GFAP	6101
Forty-one female Wistar Hannover rats , 10 -- 12 weeks old ,	6116
Forty-one female Wistar Hannover rats	6116
10 -- 12 weeks old	6155
10	6155
12 weeks	6158
2 -- 2.5 % isoflurane	6195
2	6195
2.5 % isoflurane	6197
The spinal cord	6214
approximately T9	6259
the ventral and lateral dura	6285
Injections of DMEM alone or with OEG -LRB- 200,000 per stump -RRB-	6322
Injections of DMEM alone or with OEG	6322
Injections	6322
DMEM alone or with OEG	6336
DMEM	6336
OEG	6355
200,000 per stump	6360
200,000	6360
stump	6372
1 mm	6394
the transection site at the midline	6404
the transection site	6404
the midline	6428
the dorsal surface	6458
1.75 , 1.25 , 1 , and 0.5 µm	6478
1.75	6478
1.25	6484
1	6490
0.5 µm	6497
both the rostral and caudal spinal cord stumps	6510
the rostral	6515
caudal spinal cord stumps	6531
transplantation	6564
the spine	6581
a stainless steel bar	6611
3.2 cm in length and 0.1 cm in diameter	6634
3.2 cm in length	6634
3.2 cm	6634
length	6644
0.1 cm in diameter	6655
0.1 cm	6655
diameter	6665
the T7 and T13 vertebral processes	6687
the T7	6687
T13 vertebral processes	6698
Step training and behavioral analyses	6723
Two weeks	6761
injury	6777
the rats	6785
manual step training	6800
a treadmill for 20 min/d , 5 d/week for 7.5 months	6824
a treadmill	6824
20 min/d , 5 d/week for 7.5 months	6840
20 min/d	6840
5 d/week for 7.5 months	6850
5 d/week	6850
7.5 months	6863
Kubasak	6890
et al. -LRB- 2008 -RRB-	6898
et al.	6898
2008	6906
Stepping ability	6913
transection	6951
1 and 7 months	6980
transection	7001
spinal cord retransection	7024
8 months at treadmill speeds of 10 , 13.5 , and 17.5 cm/s	7053
8 months	7053
treadmill speeds of 10 , 13.5 , and 17.5 cm/s	7065
treadmill speeds	7065
10 , 13.5 , and 17.5 cm/s	7085
10	7085
13.5	7089
17.5 cm/s	7099
a body weight support	7118
85 %	7143
i.e.	7148
the hindlimbs	7154
15 % body weight	7178
Recording of treadmill stepping	7196
Recording	7196
treadmill stepping	7209
treadmill	7209
Kubasak	7258
et al. -LRB- 2008 -RRB-	7266
et al.	7266
2008	7274
Each trial	7281
90 s of stepping	7305
90 s	7305
The highest number of plantar steps at three treadmill speeds	7323
The highest number	7323
plantar steps at three treadmill speeds	7345
plantar steps	7345
three treadmill speeds	7362
each rat	7401
5 months after transection	7414
5 months	7414
transection	7429
spinal rats	7442
quipazine -LRB- 0.3 mg/kg , i.p. -RRB- -LRB- Ichiyama et al. , 2005 -RRB-	7473
quipazine -LRB- 0.3 mg/kg , i.p. -RRB-	7473
quipazine	7473
0.3 mg/kg , i.p.	7484
0.3 mg/kg	7484
Ichiyama	7502
et al. , 2005	7511
et al.	7511
2005	7519
a 5-HT2A receptor agonist	7526
ability	7566
15 min	7585
We	7599
principal components analysis -LRB- PCA -RRB-	7607
principal components analysis	7607
PCA	7638
the consistency	7654
the toe trajectories -LRB- Fong et al. , 2005 ; Cai et al. , 2006 -RRB-	7673
the toe trajectories	7673
Fong	7695
et al. , 2005 ; Cai et al. , 2006	7700
et al.	7700
2005 ; Cai et al.	7708
2005	7708
Cai et al.	7714
Cai	7714
et al.	7718
2006	7726
stride transitions	7742
kinematics trajectories of toe markers	7787
kinematics trajectories	7787
toe markers	7814
every 0.1 s	7841
corresponding points across all measured steps	7858
corresponding points	7858
steps	7899
The first principal component	7920
an average that explains the greatest amount of variance among trajectories	7962
an average	7962
the greatest amount of variance	7987
the greatest amount	7987
variance	8010
trajectories	8025
the variance	8058
the first component was calculated as a `` score	8088
the first component	8088
a `` score	8126
A larger PCA score -LRB- i.e. , closer to 100 % -RRB-	8137
A larger PCA score	8137
100 %	8173
more	8190
The best PCA score -LRB- percentage -RRB- from three treadmill speeds	8216
The best PCA score -LRB- percentage -RRB-	8216
The best PCA score	8216
percentage	8236
three treadmill speeds	8253
each rat that performed three or more alternating steps	8292
each rat	8292
three or more	8316
steps	8342
A PCA score of 45 %	8349
A PCA score	8349
45 %	8364
the lowest PCA percentage	8369
Cai	8420
et al. -LRB- 2006 -RRB-	8424
et al.	8424
2006	8432
spinal rats that performed two or fewer alternating steps	8456
spinal rats	8456
two or fewer	8483
steps	8508
We	8515
mean stance length , step height , and trajectory length	8532
mean stance length	8532
step height	8552
trajectory length	8569
the step patterns	8603
treadmill testing	8628
Weight-support testing .	8647
Rats	8671
a harness connected to an automated body weight-support system	8697
an automated body	8720
Robomedica	8761
10 % of the rat 's body weight	8786
10 %	8786
the rat 's body weight	8793
the rat 's	8793
every 10 s	8815
the rat	8832
The percentage body weight support at collapse	8851
The percentage body weight support	8851
collapse	8889
an observer blind to the experimental status of the rat	8916
an observer	8916
the experimental status of the rat	8937
the experimental status	8937
the rat	8964
ankle joint angles	8981
good indicators of weight-support ability -LRB- Timoszyk et al. , 2002 -RRB-	9004
good indicators	9004
weight-support ability -LRB- Timoszyk et al. , 2002 -RRB-	9023
weight-support ability	9023
Timoszyk	9047
et al. , 2002	9056
et al.	9056
2002	9064
data from rats that collapsed forward	9071
data	9071
rats that collapsed forward	9081
rats	9081
the joint angle as described previously -LRB- Ichiyama et al. , 2009 -RRB-	9132
the joint angle as described previously	9132
the joint angle	9132
Ichiyama	9173
et al. , 2009	9182
et al.	9182
2009	9190
Ankle angle analyses	9197
the Simi threedimensional motion	9239
von Frey	9273
An experimenter blind to the treatment status of the spinal rats	9288
An experimenter	9288
the treatment status of the spinal rats	9313
the treatment status	9313
the spinal rats	9337
the von Frey	9363
test -LRB- Chaplan et al. , 1994 -RRB- on both hindpaws at 1	9384
test -LRB- Chaplan et al. , 1994 -RRB-	9384
test	9384
Chaplan	9390
et al. , 1994	9398
et al.	9398
1994	9406
both hindpaws at 1	9415
both hindpaws	9415
1	9432
3 , 5	9435
3	9435
5	9438
7 months after transection and 5 d after spinal cord retransection	9445
7 months after transection	9445
7 months	9445
transection	9460
5 d after spinal cord retransection	9476
5 d	9476
spinal cord retransection	9486
any injury-induced changes in the withdrawal threshold	9525
any injury-induced changes	9525
the withdrawal threshold	9555
A series	9581
nine hairs -LRB- 3.61 -- 5.46 g ,	9593
nine hairs	9593
3.61 -- 5.46 g	9605
3.61	9605
5.46 g	9610
the 4.56 g ; North Coast Medical -RRB-	9632
the 4.56 g	9632
North Coast Medical	9644
the hindpaw withdrawal response	9685
the 50 % withdrawal threshold -LRB- grams -RRB-	9730
the 50 % withdrawal threshold	9730
grams	9760
Electrophysiological assessment of hindlimb motor-evoked potentials	9768
Electrophysiological assessment	9768
hindlimb motor-evoked potentials	9803
We	9836
transcranial electric stimulation	9849
1 , 4 , and 7 months	9886
1	9886
4	9889
7 months	9896
transection of all spinal rats	9911
transection	9911
all spinal rats	9926
and 3	9964
a retransection	9984
17 rats	10003
Stimulation of four intact rats	10012
Stimulation	10012
four intact rats	10027
acute transection	10078
Rats	10097
0.7 -- 1 % isoflurane	10133
0.7	10133
1 % isoflurane	10137
stimulation	10164
the primary motor cortex -LRB- approximately bregma ≈ 3.5 to ≈ 2 mm -RRB-	10179
the primary motor cortex	10179
approximately bregma ≈ 3.5 to ≈	10205
bregma ≈ 3.5 to ≈	10219
bregma ≈	10219
3.5 to ≈	10227
2 mm	10235
a method	10247
Lo ' pez-Vales et al. -LRB- 2006 -RRB-	10270
Lo ' pez-Vales	10270
Lo '	10270
et al. -LRB- 2006 -RRB-	10284
et al.	10284
2006	10292
the brainstem -LRB- approximately bregma ≈ 6 to ≈ 10 mm -RRB-	10305
the brainstem	10305
approximately bregma ≈ 6 to ≈	10320
bregma ≈ 6 to ≈	10334
bregma ≈	10334
6 to ≈	10342
10 mm	10348
Motor-evoked potentials -LRB- MEPs -RRB-	10356
Motor-evoked potentials	10356
MEPs	10381
a series of single-pulse stimulations	10404
a series	10404
single-pulse stimulations	10416
0.1 ms duration	10443
40 to 200 mA	10465
40 mA increments	10481
30 times/intensity applied at 30 s intervals	10499
30 times/intensity	10499
30 s intervals	10529
constant-current stimulator model DS7AH -LRB- Digitimer -RRB-	10545
constant-current stimulator model DS7AH	10545
Digitimer	10586
MEPs	10599
the tibialis	10635
TA	10658
MG	10688
subcutaneously inserted needle electrodes	10705
needle : 30 gauge -LRB- BD Biosciences -RRB- ; wire	10748
needle	10748
30 gauge -LRB- BD Biosciences -RRB-	10756
30 gauge	10756
BD Biosciences	10766
wire	10783
50 µm in diameter -LRB- California Fine Wire -RRB-	10789
50 µm	10789
diameter -LRB- California Fine Wire -RRB-	10798
diameter	10798
California Fine Wire	10808
All MEPs	10832
1000x	10857
10 -- 10,000 Hz	10878
10	10878
10,000 Hz	10882
Each MEP	10894
a sharp peak	10918
a latency	10936
8 ms and an amplitude larger	10958
8 ms	10958
an amplitude larger	10967
0.05 mV	10992
Electrical stimulation with high currents as used in this study	11001
Electrical stimulation	11001
high currents as used in this study	11029
high currents	11029
this study	11054
artifacts in MEP recordings	11091
artifacts	11091
MEP recordings	11104
a result of volume conduction , stimulation of axial spinal musculature	11122
a result	11122
volume conduction , stimulation of axial spinal musculature	11134
volume conduction	11134
stimulation of axial spinal musculature	11153
stimulation	11153
axial spinal musculature	11168
the activation of cutaneous trunci pathways -LRB- Gruner et al. , 1993 -RRB-	11201
the activation	11201
cutaneous trunci pathways -LRB- Gruner et al. , 1993 -RRB-	11219
cutaneous trunci pathways	11219
Gruner	11246
et al. , 1993	11253
et al.	11253
1993	11261
Direct stimulation artifacts	11268
very short duration -LRB- i.e. , < 1 ms -RRB-	11305
very short duration	11305
i.e. , < 1 ms	11326
i.e. , <	11326
i.e.	11326
<	11332
1 ms	11333
both media and OEG animals	11360
media	11365
OEG animals	11375
we	11397
the possibility	11415
extraspinal stimulation artifacts	11434
e.g. , via cutaneous trunci pathways	11469
e.g.	11469
cutaneous trunci pathways	11479
we	11507
it	11519
such a	11536
OEG rats	11570
retransection	11606
Morphological analyses	11621
tracer injections and analyses	11655
Twenty-two chronic spinal rats	11687
n = 5	11736
n	11736
5	11740
n = 7	11758
n	11758
7	11762
n = 5	11780
n	11780
5	11784
n = 5	11800
n	11800
5	11804
horseradish peroxidase	11826
wheat germ agglutinin -LRB- WGA -- HRP -RRB- 8 months	11865
wheat germ agglutinin -LRB- WGA -- HRP -RRB-	11865
wheat germ agglutinin	11865
WGA -- HRP	11888
WGA	11888
HRP	11892
8 months	11897
transection	11912
Additional controls	11925
three	11954
three media-injected spinal rats	11971
1	12015
month	12017
transection	12029
Rats	12042
2 % isoflurane , and a 0.65 l mixture of 5 % WGA -LRB- Sigma -RRB-	12070
2 % isoflurane	12070
a 0.65 l mixture of 5 % WGA -LRB- Sigma -RRB-	12089
a 0.65 l mixture	12089
5 % WGA -LRB- Sigma -RRB-	12109
5 % WGA	12109
Sigma	12117
25 % HRP -LRB- Sigma -RRB-	12128
25 % HRP	12128
Sigma	12137
the transection in 13 locations	12170
the transection	12170
13 locations	12189
mm : midline , 1.8 , 1.4 , 1.0 , 0.8 , and 0.4 ;	12228
mm	12228
midline , 1.8 , 1.4 , 1.0 , 0.8 , and 0.4	12232
midline	12232
1.8	12241
1.4	12246
1.0 , 0.8 , and 0.4	12251
1.2 mm	12273
the right or left of the midline , 1.6 , 1.2 , 0.8 , and 0.4	12283
the right or left	12283
the midline , 1.6 , 1.2 , 0.8 , and 0.4	12304
the midline	12304
1.6	12317
1.2	12322
0.8	12327
0.4	12336
Ramo ' n-Cueto et al. , 1998 ; Mun˜oz - Quiles et al. , 2009	12365
Ramo ' n-Cueto et al. , 1998 ; Mun˜oz - Quiles et al. ,	12365
Ramo ' n-Cueto	12365
Ramo '	12365
et al. , 1998 ; Mun˜oz - Quiles et al. ,	12379
et al.	12379
1998 ; Mun˜oz - Quiles et al.	12387
1998 ; Mun˜oz	12387
1998	12387
Mun˜oz	12393
Quiles et al.	12400
Quiles	12400
et al.	12407
2009	12415
72 h	12428
the rats	12434
tissue analyses	12461
We	12478
the primary motor cortex and brainstem	12491
the primary motor cortex	12491
brainstem	12520
every third section -LRB- 40 mthick -RRB-	12542
every third section	12542
40 mthick	12563
slides forWGAimmunohistochemistry	12577
every eighth spinal cord section -LRB- 25 µm thick -RRB-	12626
every eighth spinal cord section	12626
25 µm	12660
the cervical enlargement	12678
the transection site of all WGA	12707
the transection site	12707
all WGA	12731
HRPinjected spinal rats	12739
WGA immunoreactivity	12781
long propriospinal neurons	12812
no tracer	12858
the lesion core and rostral stump	12880
None of the rats evaluated for retrograde tracing data	12929
None	12929
the rats evaluated for retrograde tracing data	12937
the rats	12937
data	12979
WGA -- HRP leakage	12988
WGA	12988
HRP leakage	12992
the lesion core	13009
rostral stump	13028
supplemental Fig. 1C	13043
www.jneurosci.org as supplemental material	13078
www.jneurosci.org	13078
supplemental material	13099
We	13123
an imaging system	13131
Simple PCI software ; Compix Imaging Systems , Hamamatsu Corporation	13150
Simple PCI software	13150
Compix Imaging Systems , Hamamatsu Corporation	13171
the optical density of WGA immunoreactivity	13229
the optical density	13229
WGA immunoreactivity	13252
brainstem and spinal cord neurons	13276
The maximum background level	13311
≈ 20 large neurons outside the regions of interest	13343
≈ 20 large neurons	13343
the regions of interest	13369
the regions	13369
interest	13384
neurons that do not project to the spinal cord	13400
neurons	13400
not project	13416
the spinal cord	13431
the maximal background level of each section	13481
the maximal background level	13481
each section	13513
Cells within the nuclei of interest	13527
Cells	13527
the nuclei of interest	13540
the nuclei	13540
interest	13554
their optical densities	13585
were5 % or greater	13609
were5 %	13609
greater	13618
the maximal background level	13631
Optical densitometry measurements	13661
every third section -LRB- 120 µm apart -RRB-	13713
every third section	13713
120 µm	13734
the red and vestibular nuclei	13759
the locus coeruleus	13793
every 12th section -LRB- 480 µm apart -RRB-	13817
every 12th section	13817
480 µm	13837
the reticular formation and raphe nucleus	13862
All measurements	13905
the transplantation or training status of the rats	13946
the transplantation or training status	13946
the rats	13988
Tissue preparation .	13998
Tissue	13998
preparation	14005
Rats	14018
ketamine -LRB- 100 mg/kg , i.p. -RRB- and xylazine -LRB- 5 mg/kg , i.p. -RRB-	14053
ketamine	14053
100 mg/kg , i.p.	14063
100 mg/kg	14063
xylazine	14084
5 mg/kg , i.p.	14094
5 mg/kg	14094
4 % paraformaldehyde	14124
4 °C	14162
4 h. Spinal cords , brains	14170
4 h. Spinal cords	14170
brains	14189
brainstems	14201
Antibodies .	14246
Monoclonal antibodies used	14258
Monoclonal antibodies	14258
the following	14294
anti-GFAP -LRB- 1:1000 ; BD Pharmingen -RRB-	14309
anti-GFAP	14309
1:1000 ; BD Pharmingen	14320
1:1000	14320
BD Pharmingen	14328
anti-Neuronal-specific Nuclear protein -LRB- NeuN -RRB- -LRB- 1:100 -RRB-	14344
anti-Neuronal-specific Nuclear protein -LRB- NeuN -RRB-	14344
anti-Neuronal-specific Nuclear protein	14344
NeuN	14384
1:100	14391
anti-GAP43 -LRB- 1 : 10,000 ; Millipore Corporation -RRB-	14403
anti-GAP43	14403
1 : 10,000 ; Millipore Corporation	14415
1 : 10,000	14415
Millipore Corporation	14426
Polyclonal antibodies used	14450
Polyclonal antibodies	14450
the following	14486
goat anti- WGA -LRB- 1:2000 ; Vector Laboratories -RRB-	14501
goat anti- WGA	14501
1:2000 ; Vector Laboratories	14516
1:2000	14516
Vector Laboratories	14524
goat anti- 5-HT -LRB- 1:20,000 ; ImmunoStar -RRB-	14546
goat anti- 5-HT	14546
1:20,000 ; ImmunoStar	14563
1:20,000	14563
ImmunoStar	14573
rabbit anti-GFAP -LRB- 1:30,000 ; Dako -RRB-	14590
rabbit anti-GFAP	14590
1:30,000 ; Dako	14608
1:30,000	14608
Dako	14618
Immunohistochemistry and lesion site analyses .	14625
Immunohistochemistry and lesion	14625
site analyses	14657
the transection site	14684
the sagittal plane -LRB- 25 µm -RRB-	14708
the sagittal plane	14708
25 µm	14728
the sections	14747
a series of 16 slides such that every 16th section	14763
a series	14763
16 slides such that every 16th section	14775
16 slides	14775
every 16th section	14795
a slide	14829
All immunohistochemistry procedures with diaminobenzidine -LRB- DAB -RRB-	14838
All immunohistochemistry procedures	14838
diaminobenzidine -LRB- DAB -RRB-	14879
diaminobenzidine	14879
DAB	14897
the monoclonal , polyclonal , or double immunolabeling protocols	14912
Takeoka	14997
et al. , 2009 , 2010	15005
et al.	15005
2009	15013
2010	15019
immunofluorescence of GFAP and NeuN	15030
immunofluorescence	15030
GFAP and NeuN	15052
we	15067
the presoak and Triton X-100 steps	15078
Species appropriate Alexa Fluor 488 and 584 -LRB- 1:200 ; Invitrogen -RRB-	15114
Species appropriate Alexa Fluor 488 and 584	15114
Species appropriate Alexa Fluor	15114
1:200 ; Invitrogen	15159
1:200	15159
Invitrogen	15166
localization	15192
Quantification of 5-HT axons and GAP43 somata .	15206
Quantification	15206
5-HT axons and GAP43 somata	15224
5-HT axons	15224
GAP43 somata	15239
5-HT axons	15253
Takeoka	15295
et al. -LRB- 2009 -RRB-	15303
et al.	15303
2009	15311
GAP43-positive somata	15318
the lower thoracic cord caudal to the original lesion	15351
the lower thoracic cord caudal	15351
the original lesion	15385
every eighth section of the caudal stump	15424
every eighth section	15424
the caudal stump	15448
tissue volume	15489
Volume of the lesion core and associated cavities .	15504
Volume	15504
the lesion core and associated cavities	15514
the lesion core	15514
associated cavities	15534
Approximately 85 % of the lesion site	15555
Approximately 85 %	15555
the lesion site	15576
GFAP	15596
the lesion core	15622
all transections	15671
all rats	15706
the GFAP-negative core	15716
the GFAP-positive rostral and caudal stumps	15756
the GFAP-positive rostral	15756
caudal stumps	15786
our previous study -LRB- Kubasak et al. , 2008 -RRB-	15815
our previous study	15815
Kubasak	15835
et al. , 2008	15843
et al.	15843
2008	15851
The volume of the lesion core and the associated cavities	15858
The volume	15858
the lesion core and the associated cavities	15872
the lesion core	15872
the associated cavities	15892
reported -LRB- Kubasak et al. , 2008 -RRB-	15934
reported	15934
Kubasak	15944
et al. , 2008	15952
et al.	15952
2008	15960
We	15967
the GFAP-negative transection site	15979
the nearby cavities	16018
all rats injected with the retrograde tracer -LRB- n = 22 rats -RRB-	16041
all rats	16041
the retrograde tracer -LRB- n = 22 rats -RRB-	16064
the retrograde tracer	16064
n	16087
22 rats	16091
The GFAP-positive area	16101
the total section area in every eighth section -LRB- 25 µm thick -RRB-	16144
the total section area	16144
every eighth section -LRB- 25 µm thick -RRB-	16170
every eighth section	16170
25 µm	16192
tissue volume	16229
We	16244
differences between the media and OEG groups	16258
differences	16258
the media and OEG groups	16278
there	16311
no training effects	16322
Length of the non-neuronal tissue and lesion core.Wedouble	16343
Length	16343
the non-neuronal tissue and lesion core.Wedouble	16353
every eighth section	16410
GFAP and NeuN	16435
the extent of lesion-induced neuronal degeneration	16461
the extent	16461
lesion-induced neuronal degeneration	16475
spinal cord tissue rostral	16515
caudal	16546
the injury site	16556
We	16573
-LRB- 1 -RRB- the shortest distance between NeuN-labeled neurons	16585
the shortest distance	16589
NeuN-labeled neurons	16619
the GFAP-positive border	16644
the GFAP-negative lesion core in both the rostral and caudal stumps	16681
the GFAP-negative lesion core	16681
both the rostral and caudal stumps	16714
the rostral	16719
caudal stumps	16735
-LRB- 2 -RRB- the total lengths of the non-neuronal region and the lesion core	16753
the total lengths	16757
the non-neuronal region and the lesion core	16778
the non-neuronal region	16778
the lesion core	16806
Statistical analyses	16823
The nonparametric Mann -- Whitney test was used for the von Frey analyses .	16845
The nonparametric Mann	16845
Whitney test	16868
the von Frey analyses	16894
All other statistical comparisons	16917
nonparametric resampling analyses	16971
group	17016
differences	17027
the assumptions	17052
the underlying data distribution -LRB- Efron and Tibshirani , 1991 -RRB-	17071
the underlying data distribution	17071
Efron and Tibshirani , 1991	17105
Efron	17105
Tibshirani , 1991	17115
Tibshirani	17115
1991	17127
Results Table 1 .	17135
Results	17135
Table 1	17143
Quantification of WGA-labeled cell bodies from the retrograde	17152
Quantification	17152
WGA-labeled cell bodies from the retrograde	17170
WGA-labeled cell bodies	17170
the retrograde	17199
study Figure 1	17222
OEG transplantation and long-term step training	17239
influence locomotor function in spinal rats	17287
influence locomotor function	17287
spinal rats	17319
, Ankle flexion and extension -LRB- highlighted in pink -RRB-	17333
, Ankle flexion	17333
Ankle flexion	17335
extension -LRB- highlighted in pink -RRB-	17353
extension	17353
pink	17379
successful plantar stepping , which is rarely	17402
successful plantar	17402
adult spinal rats	17459
Stepping	17478
the left -LRB- stick representation is sampled every 0.2 s -RRB-	17506
the left	17506
stick representation	17516
every 0.2 s	17548
Step heights of spinal plantar steppers	17562
Step heights	17562
spinal plantar steppers	17578
those of intact rats	17629
those	17629
intact rats	17638
Foot -LRB- pink -RRB-	17651
Foot	17651
the treadmill	17685
successful plantar steps	17706
intact rats	17744
their footpads	17769
the foot of nonplantar steppers and draggers	17793
the foot	17793
nonplantar steppers and draggers	17805
the treadmill.B	17853
Step trajectories of intact rats	17870
Step trajectories	17870
intact rats	17891
those of spinal rats	17927
those	17927
spinal rats	17936
Each colored line	17961
a single step	17989
the thick red line	18008
the average trajectory	18038
Step height	18062
stance and step trajectory lengths	18087
shorter in media - and OEG-injected spinal rats than intact rats	18126
shorter in media - and OEG-injected spinal rats	18126
media	18137
intact rats	18178
C , OEG-untrained rats	18191
more plantar steps than media-untrained rats	18223
more plantar steps	18223
media-untrained rats	18247
1	18271
3	18274
5 months -LRB- * p < 0.05 -RRB- and more plantar steps than OEG-trained rats	18281
5 months -LRB- * p < 0.05 -RRB-	18281
p <	18292
p	18292
<	18293
0.05	18294
more plantar steps than OEG-trained rats	18304
more plantar steps	18304
OEG-trained rats	18328
1 month -LRB- # p < 0.05 -RRB-	18348
1 month	18348
# p < 0.05	18358
# p	18358
< 0.05	18361
<	18361
0.05	18363
D , PCA	18370
D	18370
PCA	18373
OEG groups	18394
more consistent step trajectories	18414
both media groups	18453
1 , 3 , and 5 months -LRB- * p < 0.05 -RRB-	18474
1	18474
3	18477
5 months -LRB- * p < 0.05 -RRB-	18484
p <	18495
p	18495
<	18496
0.05	18497
OEG-untrained rats	18504
higher	18530
OEG-trained rats	18542
1 month -LRB- # p < 0.05 -RRB-	18562
1 month	18562
# p < 0.05	18572
# p	18572
< 0.05	18574
<	18574
0.05	18575
E , OEG and media groups	18582
their stance and trajectory lengths	18618
all time points	18657
p <	18675
p	18675
<	18676
0.05	18677
F , Step training	18684
the number of plantar steps	18710
the number	18710
plantar steps	18724
10 s in response	18747
10 s	18747
response	18755
5-HT2A receptor activation	18767
p <	18796
p	18796
0.05 ; see supplemental videos	18799
0.05	18799
supplemental videos	18809
available at www.jneurosci.org as supplemental material	18830
www.jneurosci.org as supplemental	18843
www.jneurosci.org	18843
supplemental	18864
Data for individual rats	18888
Data	18888
individual rats	18897
a circle or square	18932
OEG injection	18958
training	18985
step consistency -LRB- G -RRB- and stance and trajectory lengths -LRB- H -RRB-	19003
step consistency	19003
G	19021
stance and trajectory lengths	19028
H	19059
quipazine injection -LRB- * p < 0.05 -RRB-	19068
quipazine injection	19068
p <	19090
p	19090
<	19091
0.05	19092
I	19099
OEG-trained rats	19102
better ankle extension	19127
all other rats	19155
the hindlimbs	19175
10 % of their body weight at 7 months after transection -LRB- * p < 0.05 -RRB-	19203
10 % of their body weight at 7 months after transection	19203
10 %	19203
their body weight	19210
7 months	19231
transection	19246
p <	19260
p	19260
<	19261
0.05	19262
Data	19269
mean ± SEM	19278
Figure 2 .	19290
Figure	19290
2	19297
Retransection experiments	19300
functional regeneration	19343
motor recovery	19382
rats	19414
more plantar steps	19428
retransection -LRB- after minus before retransection ; * p = 0.01 -RRB-	19465
retransection	19465
retransection ; * p	19499
retransection	19499
p	19515
= 0.01	19516
whereas mediainjected rats	19524
p < 0.34	19567
p	19567
< 0.34	19569
<	19569
0.34	19571
Data for individual rats	19578
Data	19578
individual rats	19587
a circle	19622
B , OEG-injected rats	19632
more consistent step trajectories after than before retransection	19658
more consistent step trajectories	19658
retransection	19710
p <	19726
p	19726
<	19728
0.05	19730
Media groups	19737
C	19766
retransection	19775
OEG-trained rats	19790
longer stance and step trajectory lengths than OEG-untrained rats	19812
longer stance and step trajectory lengths	19812
OEG-untrained rats	19859
p <	19880
p	19880
<	19882
0.05	19884
D , E ,	19891
D	19891
E	19894
quipazine injection	19903
retransection	19924
the step consistency of any group -LRB- D -RRB-	19952
the step consistency	19952
any group -LRB- D -RRB-	19976
any group	19976
D	19987
Only the OEG-trained group	19991
stance and step trajectory lengths	20029
retransection -LRB- E ; * p < 0.05 -RRB-	20082
retransection	20082
E ; * p < 0.05	20097
E ; * p <	20097
E	20097
p	20101
<	20102
0.05	20103
F	20110
transplantation or training status	20127
all spinal rats	20163
mechanical hindpaw stimulation between 1 and 5 months after transection	20202
mechanical hindpaw stimulation	20202
1 and 5 months after transection	20241
1 and 5 months	20241
transection	20262
7 months	20278
media	20288
groups	20294
OEG groups	20334
a higher withdrawal threshold	20379
p <	20411
p	20411
<	20412
0.001	20413
Spinal cord retransection -LRB- retx -RRB-	20421
Spinal cord retransection	20421
retx	20448
the improvement observed in OEG-injected rats -LRB- # p < 0.001 -RRB-	20463
the improvement	20463
OEG-injected rats -LRB- # p < 0.001 -RRB-	20491
OEG-injected rats	20491
# p < 0.001	20511
# p	20511
< 0.001	20514
<	20514
0.001	20516
no effect on mediainjected rats -LRB- p = 0.65 -RRB-	20531
no effect	20531
mediainjected rats -LRB- p = 0.65 -RRB-	20544
mediainjected rats	20544
p	20565
0.65	20567
Data	20574
mean ± SEM	20583
OEG-untrained and - trained groups	20594
OEG-untrained	20594
- trained groups	20612
A and B because of a lack of a training effect	20645
A and B	20645
a lack of a training effect	20664
a lack	20664
a training effect	20674
Figure 3 .	20694
Figure	20694
3	20701
OEG	20704
functional reconnections of descending pathways across the transection	20716
functional reconnections	20716
descending pathways across the transection	20744
descending pathways	20744
the transection	20771
top trace	20795
an MEP -LRB- ≈ 8 ms latency -RRB- from the MG of an intact	20816
an MEP -LRB- ≈ 8 ms latency -RRB-	20816
an MEP	20816
≈ 8 ms latency	20824
≈ 8 ms	20824
latency	20830
the MG of an intact	20844
the MG	20844
an intact	20854
brainstem stimulation	20883
The bottom three traces	20906
recordings from the left MG of an OEG-injected rat	20934
recordings	20934
the left MG of an OEG-injected rat	20950
the left MG	20950
an OEG-injected rat	20965
MEPs	20986
1 month	21009
transection	21023
7 months	21039
a typical MEP	21049
a small amplitude -LRB- ≈ 0.25 mV -RRB- and long latency -LRB- ≈ 20 ms -RRB-	21067
a small amplitude -LRB- ≈ 0.25 mV -RRB-	21067
a small amplitude	21067
≈ 0.25 mV	21086
long latency -LRB- ≈ 20 ms -RRB-	21100
long latency	21100
≈ 20 ms	21114
Retransection rostral to the initial transection site	21123
Retransection rostral	21123
the initial transection site	21148
the MEP signals -LRB- bottom trace , retx -RRB-	21187
the MEP signals	21187
bottom trace , retx	21204
B , Only OEG-injected rats	21225
MEPs	21261
4 and 7 months	21269
Several OEG-injected spinal rats	21285
MEPs	21328
both cortical and brainstem stimulation	21336
at 4 and 7 months	21376
C , The MEP amplitude in response to brainstem stimulation	21395
C	21395
The MEP amplitude in response to brainstem stimulation	21398
The MEP amplitude	21398
response to brainstem stimulation	21419
response	21419
brainstem stimulation	21431
the OEG-trained than OEG-untrained group -LRB- * p < 0.05 -RRB-	21467
the OEG-trained than OEG-untrained group	21467
p <	21510
p	21510
<	21511
0.05	21512
the latency	21523
D	21551
MEPs	21559
OEG-injected rats	21581
> 50 %	21599
>	21599
MEP	21615
multiple muscles	21622
7 months	21642
E , MoreMGmuscles	21652
E	21652
MoreMGmuscles	21655
brainstem stimulation than TA muscles	21682
brainstem stimulation	21682
TA muscles	21709
7 months	21723
injury	21738
Higher stimulation intensities	21746
more MEPs	21785
both muscles	21798
The total number of muscles across all OEG-injected rats	21812
The total number	21812
muscles across all OEG-injected rats	21832
muscles	21832
all OEG-injected rats	21847
F	21879
An OEG-treated rat	21882
multiple MEPs	21906
long latencies -LRB- * -RRB-	21925
long latencies	21925
the right MG after 10 consecutive stimulations at 160 mA	21947
the right MG	21947
10 consecutive stimulations at 160 mA	21966
10 consecutive stimulations	21966
160 mA	21997
Responses	22005
MEP in blue traces and no response in red traces	22040
MEP in blue traces	22040
MEP	22040
blue traces	22047
no response in red traces	22063
no response	22063
red traces	22078
latency and amplitude	22104
G , Both the latency and amplitude of MEPs recorded from OEG rats	22127
G	22127
the latency	22135
amplitude of MEPs recorded from OEG rats	22151
amplitude	22151
MEPs recorded from OEG rats	22164
MEPs	22164
OEG rats	22183
those from intact rats	22211
those	22211
intact rats	22222
p <	22236
p	22236
<	22237
0.05	22238
MEPs in response to cortical and brainstem stimulation	22245
MEPs	22245
response to cortical and brainstem stimulation	22253
response	22253
cortical and brainstem stimulation	22265
cortical	22265
brainstem stimulation	22278
latency	22314
amplitude at 7 than 4 months -LRB- # p < 0.05 -RRB-	22336
amplitude	22336
7 than 4 months -LRB- # p < 0.05 -RRB-	22349
7 than 4 months	22349
# p < 0.05	22367
# p	22367
< 0.05	22369
<	22369
0.05	22370
No MEPs	22377
media-injected rats	22402
OEG-untrained and - trained groups	22423
OEG-untrained	22423
- trained groups	22441
B , D , E , and G due to the lack of a training effect	22474
B , D , E , and G	22474
the lack of a training effect	22496
the lack	22496
a training effect	22508
Figure 4 .	22528
Figure	22528
4	22535
WGA-immunolabeled somata	22538
coronal brainstem sections	22578
parasagittal sections	22609
the cervical enlargement	22634
A	22670
B	22690
C	22712
WGA -- HRP labels projection neurons in five brainstem nuclei	22724
WGA	22724
HRP	22728
projection neurons in five brainstem nuclei	22739
projection neurons	22739
five brainstem nuclei	22761
long propriospinal neurons	22787
laminae VII	22817
VIII of the cervical spinal cord in intact rats	22829
VIII	22829
the cervical spinal cord in intact rats	22837
the cervical spinal cord	22837
intact rats	22865
B , C , Fewer WGA-positive somata	22878
B	22878
C , Fewer WGA-positive somata	22881
C	22881
Fewer WGA-positive somata	22884
media-injected -LRB- B -RRB- and OEG-injected -LRB- C -RRB- rats	22927
B	22943
C	22964
the same areas of intact rats -LRB- A -RRB-	22980
the same areas	22980
intact rats -LRB- A -RRB-	22998
intact rats	22998
A	23011
Scale bars	23015
red nucleus , locus ceruleus , and vestibular nucleus , 100 µm	23027
red nucleus , locus ceruleus ,	23027
red nucleus	23027
locus ceruleus	23040
vestibular nucleus , 100 µm	23060
vestibular nucleus	23060
100 µm	23080
raphe nucleus and reticular formation , 50 µm	23088
raphe nucleus and reticular formation	23088
50 µm	23127
cervical spinal cord , 25 µm	23134
cervical spinal cord	23134
25 µm	23156
D , The number of WGA-labeled somata	23163
D	23163
The number of WGA-labeled somata	23166
The number	23166
WGA-labeled somata	23180
OEG-injected than in short - or long-term media groups	23215
short - or long-term media	23236
all areas -LRB- * p < 0.05 for all comparisons -RRB-	23272
all areas	23272
p <	23284
p	23284
<	23285
0.05 for all comparisons	23286
0.05	23286
all comparisons	23295
the reticular formation	23319
Short - and long-term media controls	23344
Short - and long-term media	23344
brainstem nuclei	23398
the cervical spinal cord	23421
WGA-positive somata in the reticular formation	23447
WGA-positive somata	23447
the reticular formation	23470
any groups	23517
Error bars	23529
SEM	23544
Figure 5 .	23550
Figure	23550
5	23557
Axons	23560
OEG-injected rats	23580
A 5-HT-labeled axon	23602
-LRB- black , arrowheads -RRB- projects	23622
black , arrowheads	23623
black	23623
arrowheads	23630
the	23666
site	23682
an OEG-injected rat	23690
Rostral and caudal GFAP-positive borders -LRB- brown -RRB-	23711
Rostral and caudal GFAP-positive borders	23711
brown	23753
the top and bottom of the image	23767
the top and bottom	23767
the image	23789
B , C , Many 5-HT axons -LRB- black -RRB-	23800
B , C , Many 5-HT axons	23800
B	23800
C	23803
Many 5-HT axons	23806
the rostral GFAP-positive border -LRB- brown , at the top -RRB-	23836
the rostral GFAP-positive border	23836
brown , at the top	23870
brown	23870
the top	23880
both media-injected -LRB- B -RRB- and OEG-injected -LRB- C -RRB- rats	23892
media-injected -LRB- B -RRB-	23897
OEG-injected -LRB- C -RRB- rats	23920
C	23934
D , More 5-HT axons	23943
D	23943
More 5-HT axons	23946
the lesion core of OEG	23979
the lesion core	23979
OEG	23998
media-injected rats -LRB- * p = 0.02 -RRB-	24008
media-injected rats	24008
p = 0.02	24030
p	24030
= 0.02	24031
E , Diagram of the injury site of the retransected spinal cord .	24039
E	24039
Diagram of the injury site of the retransected spinal cord	24042
Diagram	24042
the injury site of the retransected spinal cord	24053
the injury site	24053
the retransected spinal cord	24072
the	24072
spinal cord	24089
Only GAP43 expression	24102
somata within the caudal stump -LRB- * -RRB- after retransection	24127
somata	24127
the caudal stump -LRB- * -RRB- after retransection	24141
the caudal stump -LRB- * -RRB-	24141
the caudal stump	24141
retransection	24168
axon regeneration of ascending axons	24191
axon regeneration	24191
axons	24222
F	24229
G	24232
GAP43-positive cell bodies -LRB- black -RRB-	24235
GAP43-positive cell bodies	24235
media -LRB- F -RRB- and OEG -LRB- G -RRB-	24273
media	24273
F	24280
OEG	24288
G	24293
GFAP-positive caudal stumps -LRB- brown -RRB-	24296
GFAP-positive caudal stumps	24296
brown	24325
H , More GAP43-positive somata	24333
H	24333
More GAP43-positive somata	24336
the caudal stump of OEG	24379
the caudal stump	24379
OEG	24399
media-injected rats -LRB- * p < 0.01 -RRB-	24409
media-injected rats	24409
p <	24431
p	24431
<	24432
0.01	24433
Scale bars	24440
50 m. Data	24452
mean ± SEM	24467
Figure 6 .	24479
Figure	24479
6	24486
OEG transplantation	24489
spinal cord tissue	24519
A , B	24539
A	24539
B	24542
neurons -LRB- C -- F -RRB- around the transection site	24549
neurons -LRB- C -- F -RRB-	24549
neurons	24549
C -- F	24558
C	24558
F	24560
the transection site	24571
A , The GFAP-negative lesion core	24593
GFAP-negative lesion	24600
GFAP-negative	24600
lesion	24614
surrounding cavitations -LRB- asterisks -RRB-	24630
surrounding cavitations	24630
asterisks	24655
the volume of tissue degeneration	24692
the volume	24692
tissue degeneration	24706
B , Media-injected rats	24727
a larger lesion core	24755
cavities	24791
OEG-injected rats	24805
p <	24825
p	24825
<	24827
0.05	24829
C	24836
injury-induced neuronal degeneration	24851
a sagittal section containing the lesion core of a media-injected rat	24889
a sagittal section	24889
the lesion core of a media-injected rat	24919
the lesion core	24919
a media-injected rat	24938
GFAP and NeuN	24982
Neuron-free regions	24997
E	25032
the transection	25051
the minimum distance	25071
the rostral and caudal stump neurons -LRB- arrows , designated as F -RRB-	25100
the rostral	25100
caudal stump neurons -LRB- arrows , designated as F -RRB-	25116
caudal stump neurons	25116
arrows , designated as F	25138
arrows	25138
F	25160
D , An example of an OEG-injected rat	25179
D	25179
An example of an OEG-injected rat	25182
An example	25182
an OEG-injected rat	25196
neurons -LRB- red -RRB-	25227
neurons	25227
red	25236
the GFAP -LRB- green -RRB-	25256
the GFAP	25256
negative lesion core -LRB- asterisk -RRB-	25273
negative lesion core	25273
asterisk	25295
E , Distance between the most proximal neurons and the lesion border	25306
E	25306
Distance between the most proximal neurons and the lesion border	25309
Distance	25309
the most proximal neurons and the lesion border	25326
the most proximal neurons	25326
the lesion border	25356
OEG	25388
media groups -LRB- see E in C ; * p < 0.001 -RRB-	25397
media groups	25397
E	25415
C ; * p < 0.001	25420
C	25420
p <	25424
p	25424
<	25425
0.001	25426
F , Average distance between neurons in the rostral and caudal stumps	25434
F	25434
Average distance between neurons in the rostral and caudal stumps	25437
Average distance	25437
neurons in the rostral and caudal stumps	25462
neurons	25462
the rostral and caudal stumps	25473
the rostral	25473
caudal stumps	25489
F	25508
C	25513
smaller in OEG - than media-injected rats -LRB- * p < 0.01 -RRB-	25519
smaller	25519
OEG	25530
media-injected rats -LRB- * p < 0.01 -RRB-	25540
media-injected rats	25540
p <	25562
p	25562
<	25563
0.01	25564
Scale bars : A , C , 400µm ; D , 50µm .	25571
Scale bars	25571
A	25583
C	25586
400µm	25589
D , 50µm	25596
D	25596
50µm	25599
Error bars	25605
SEM	25620
Figure 7 .	25626
Figure	25626
7	25633
OEG	25636
anti-p75-NGFR	25656
ED1-labeled macrophages	25674
8 months	25714
transection	25729
A , B , Hoechst-labeled nuclei -LRB- blue -RRB-	25742
A , B , Hoechst-labeled nuclei	25742
B	25745
blue	25772
p75-NGFR-positive cells -LRB- red -RRB-	25795
p75-NGFR-positive cells	25795
red	25820
the presence	25837
transplanted OEG -LRB- white arrowheads -RRB-	25853
transplanted OEG	25853
white arrowheads	25871
the rostral -LRB- A -RRB- and caudal -LRB- B -RRB-	25892
the rostral	25892
A	25905
caudal	25912
B	25920
spinal cord stumps	25923
C	25943
Hoechst-labeled nuclei -LRB- blue ; white arrowheads -RRB-	25946
Hoechst-labeled nuclei	25946
blue ; white arrowheads	25970
blue	25970
white arrowheads	25976
p75-NGFR-positive cells -LRB- red -RRB- in the lesion core	26001
p75-NGFR-positive cells -LRB- red -RRB-	26001
p75-NGFR-positive cells	26001
red	26026
the lesion core	26034
OEG but Schwann cells within the transection	26061
OEG but Schwann cells	26061
the transection	26090
p75-NGFR	26119
D , Most ED1-labeled macrophages -LRB- red ; white arrowheads -RRB-	26129
D	26129
Most ED1-labeled macrophages -LRB- red ; white arrowheads -RRB-	26132
Most ED1-labeled macrophages	26132
red ; white arrowheads	26162
red	26162
white arrowheads	26167
Hoechst-positive nuclei -LRB- blue -RRB-	26208
Hoechst-positive nuclei	26208
blue	26233
Scale bars , 25µm .	26240
Scale bars	26240
25µm	26252
Figure 8 .	26259
Figure	26259
8	26266
Summary diagram	26269
axon regeneration and caudal stump reorganization	26292
axon regeneration	26292
caudal stump reorganization	26314
sensorimotor function	26362
a complete transection -LRB- approximately T9 , curved red line -RRB-	26409
a complete transection	26409
approximately T9	26433
curved red line	26451
the lumbar spinal cord -LRB- SC -RRB-	26469
the lumbar spinal cord	26469
SC	26493
supraspinal and rostral spinal connections	26514
Middle row	26558
8 months after lesion	26573
8 months	26573
lesion	26588
media-untrained rats	26596
little evidence	26622
locomotor recovery -LRB- small oval , thin red outline -RRB-	26641
locomotor recovery	26641
small oval , thin red outline	26661
hypersensitive hindlimb withdrawal -LRB- large oval , thin blue outline -RRB-	26695
hypersensitive hindlimb withdrawal	26695
large oval , thin blue outline	26731
OEG-trained rats , direct or indirect connections , i.e.	26766
OEG-trained rats	26766
direct or indirect connections	26784
connections including long and short propriospinal neurons ,	26822
connections	26822
long and short propriospinal neurons	26844
the transection that activate or suppress lumbar somatic motor neurons	26900
the transection	26900
lumbar somatic motor neurons	26942
OEG-trained rats	26986
locomotor circuits -LRB- small oval , thick red outline -RRB-	27017
locomotor circuits	27017
small oval , thick red outline	27037
less sensitive hindlimb withdrawal -LRB- small oval , thin blue outline -RRB-	27072
less sensitive hindlimb withdrawal	27072
thin blue outline	27120
retransection -LRB- approximately T6 , straight red line -RRB-	27156
retransection	27156
approximately T6	27171
straight red line	27189
locomotor and hindlimb withdrawal functions of mediauntrained rats	27223
locomotor and hindlimb withdrawal functions	27223
mediauntrained rats	27270
OEG-trained rats	27291
thick red outline	27333
mechanical stimulation -LRB- large oval , thin blue outline -RRB-	27381
mechanical stimulation	27381
thin blue outline	27417
Retransection	27437
the suppression of the sensorimotor function	27459
the suppression	27459
the sensorimotor function	27478
Corticospinal neurons	27505
brainstem projection neurons	27543
spinal interneurons , i.e. , long and short propriospinal neurons ,	27591
spinal interneurons	27591
i.e.	27612
propriospinal neurons	27633
suppression or facilitation	27697
motor functions	27728
Axons drawn in dotted lines	27759
Axons	27759
dotted lines	27774
only anatomical evidence of regeneration	27796
only anatomical evidence	27796
regeneration	27824
The size of spinal circuits	27838
The size	27838
spinal circuits	27850
the relative contribution	27877
the functional outcome	27906
changes in thickness of	27934
changes	27934
thickness of	27945
thickness	27945
locomotor function	27971
the extent of intraspinal reorganization	28000
the extent	28000
intraspinal reorganization	28014
a complete spinal cord transection at T9	28049
a complete spinal cord transection	28049
T9	28087
spinal rats	28091
injections of olfactory bulb-derived OEG suspended in media or media alone	28112
injections	28112
olfactory bulb-derived OEG suspended in media or media alone	28126
olfactory bulb-derived OEG	28126
media or media	28166
Long-term step training of one half of the spinal rats	28188
Long-term step training	28188
one half of the spinal rats	28215
one half	28215
the spinal rats	28227
2 weeks	28251
transection	28265
20 min/d , 5 d/week	28295
20 min/d	28295
5 d/week	28305
7.5 months	28318
The four experimental groups	28330
media-untrained -LRB- n = 9 -RRB-	28376
media-untrained	28376
n	28393
9	28397
n = 10	28416
n	28416
= 10	28418
n = 11	28440
n	28440
= 11	28442
OEG-trained -LRB- n = 9 -RRB-	28453
OEG-trained	28453
n	28466
9	28470
Eight months	28474
the initial transection	28493
50 % of the spinal rats	28518
50 %	28518
the spinal rats	28525
a complete retransection rostral to the original lesion , and the remaining 50 %	28550
a complete retransection rostral	28550
the original lesion	28586
the remaining 50 %	28611
a retrograde tracer	28648
OEG transplantation	28669
hindlimb step performance	28698
Plantar foot placement	28724
hindlimb	28754
a series of joint movements	28781
a series	28781
joint movements	28793
knee and ankle flexion	28816
the swing phase and ankle extension during the stance phase	28846
the swing phase and ankle extension	28846
the stance phase	28889
adult spinal rats -LRB- Fig. 1A -RRB- -LRB- Edgerton et al. , 2004 -RRB-	28947
adult spinal rats -LRB- Fig. 1A -RRB-	28947
adult spinal rats	28947
Fig. 1A	28966
Edgerton	28976
et al. , 2004	28985
et al.	28985
2004	28993
Step trajectories of spinal rats	29000
Step trajectories	29000
spinal rats	29021
PCAare often erratic	29045
PCAare	29045
those of intact rats -LRB- Fig. 1B -RRB-	29080
those	29080
intact rats -LRB- Fig. 1B -RRB-	29089
intact rats	29089
Fig. 1B	29102
OEG transplantation	29133
hindlimb stepping ability in adult spinal rats	29162
hindlimb	29162
ability in adult spinal rats	29180
ability	29180
adult spinal rats	29191
we	29210
the number of plantar steps taken by media - and OEG-untrained spinal rats	29228
the number	29228
plantar steps taken by media - and OEG-untrained spinal rats	29242
plantar steps taken by media	29242
plantar steps	29242
media	29265
OEG-untrained spinal rats	29276
OEG-untrained rats	29303
significantly more plantar steps	29332
mediauntrained rats	29370
1	29393
5 months after transection but not at later time points -LRB- Fig. 1C -RRB-	29395
5 months	29395
transection	29410
later time points -LRB- Fig. 1C -RRB-	29433
later time points	29433
Fig. 1C	29452
Neither the media - nor the OEG-untrained rats	29462
the media - nor the OEG-untrained rats	29470
the media	29470
nor the OEG-untrained rats	29481
their plantar	29517
ability	29540
time -LRB- Fig. 1C -RRB-	29553
time	29553
Fig. 1C	29559
we	29574
there	29598
a training effect	29608
The average number of plantar steps	29627
The average number	29627
plantar steps	29649
the media-untrained and - trained groups	29700
the media-untrained	29700
groups	29733
the study -LRB- Fig. 1C -RRB-	29751
the study	29751
Fig. 1C	29762
The OEG-untrained group	29772
many or more plantar steps	29821
the OEG-trained group	29853
significant differences	29881
the study -LRB- Fig. 1C -RRB-	29923
the study	29923
Fig. 1C	29934
We	29944
PCA	29952
the consistency of the step trajectories	29969
the consistency	29969
the step trajectories	29988
stance lengths , step heights , and trajectory lengths	30028
stance lengths	30028
step heights	30044
trajectory lengths	30062
PCA analysis	30082
locomotor movement , i.e. , hindlimb alternation	30127
locomotor movement	30127
i.e. , hindlimb alternation	30147
i.e.	30147
hindlimb alternation	30153
hindlimb plantar placement	30190
The stepping pattern	30218
higher PCA scores	30275
both OEG-untrained	30298
trained groups	30322
media groups at 1 , 3 , and 5 but not at 7 months -LRB- Fig. 1D -RRB-	30351
media groups	30351
1 , 3 , and 5 but not at 7 months -LRB- Fig. 1D -RRB-	30367
1 , 3 , and 5	30367
7 months -LRB- Fig. 1D -RRB-	30390
Fig. 1D	30400
The OEGuntrained rats	30410
higherPCAscores than OEG-trained rats	30436
higherPCAscores	30436
OEG-trained rats	30457
1	30477
month	30479
Both OEG groups	30486
stance and trajectory lengths	30522
media groups	30557
the duration of the study -LRB- Fig. 1E -RRB-	30581
the duration	30581
the study -LRB- Fig. 1E -RRB-	30597
the study	30597
Fig. 1E	30608
Mean step height	30618
groups at any time point	30656
groups	30656
any time point	30666
there	30686
no improvement	30696
step consistency	30714
step height	30732
stance and trajectory lengths over time in any group	30748
stance and trajectory lengths	30748
time in any group	30783
time	30783
any group	30791
these results	30812
OEG transplantation	30840
ability	30887
these improvements	30900
the study	30937
no change over time	30952
no change	30952
time	30967
OEG transplantation and step training	30973
plantar	31019
ability	31036
5-HT2A receptor activation Administration	31060
quipazine , a 5-HT2A receptor agonist ,	31105
quipazine	31105
a 5-HT2A receptor agonist	31116
the lumbosacral locomotor networks	31169
spinal rats -LRB- Gerasimenko et al. , 2007 ; Ichiyama et al. , 2008 -RRB-	31207
spinal rats	31207
Gerasimenko	31220
et al. , 2007 ; Ichiyama et al. , 2008	31232
et al.	31232
2007 ; Ichiyama et al.	31240
2007	31240
Ichiyama et al.	31246
Ichiyama	31246
et al.	31255
2008	31263
We	31270
a single injection of quipazine	31288
a single injection	31288
quipazine	31310
5 months	31320
transection	31335
the extent	31360
OEG transplantation and/or step training	31380
OEG transplantation	31380
step training	31407
the locomotor circuitry associated with 5-HT2A receptors	31430
the locomotor circuitry	31430
5-HT2A receptors	31470
The administration of quipazine	31488
The administration	31488
quipazine	31510
the number of consecutive plantar steps	31542
the number	31542
consecutive plantar steps	31556
consistency	31592
step height	31605
stance and step trajectory lengths in all four treatment groups	31622
stance and step trajectory lengths	31622
all four treatment groups	31660
their predrug performance -LRB- supplemental Videos 1 -- 4 , available at www	31700
their predrug performance -LRB- supplemental Videos 1 -- 4 ,	31700
their predrug performance	31700
supplemental Videos 1 -- 4	31727
supplemental Videos	31727
1 -- 4	31747
www	31765
jneurosci.org	31770
supplemental material	31787
supplemental	31787
material	31800
we	31820
a training effect	31838
plantar stepping without quipazine	31859
plantar	31859
quipazine	31884
activation of the 5-HT2A receptors by quipazine	31895
activation	31895
the 5-HT2A receptors by quipazine	31909
the 5-HT2A receptors	31909
quipazine	31933
a refinement	31952
plantar	31968
ability in media - and OEG-trained spinal rats -LRB- Fig. 1F , 17.5 cm/s -RRB-	31985
ability	31985
media - and OEG-trained spinal rats -LRB- Fig. 1F , 17.5 cm/s -RRB-	31996
media	31996
OEG-trained spinal rats	32007
Fig. 1F	32032
17.5 cm/s	32041
addition	32056
5-HT2A receptor activation	32066
a more consistent	32105
pattern -LRB- Fig. 1G -RRB-	32132
pattern	32132
Fig. 1G	32141
stance and trajectory lengths	32154
Fig. 1H	32197
the OEG	32209
the media groups	32231
These results	32249
long-term step training and OEG transplantation	32277
long-term step training	32277
OEG transplantation	32305
the reorganization	32340
the lumbosacral locomotor networks	32362
serotonergic -LRB- 5-HT -RRB- receptor activation	32409
5-HT	32423
Only OEG-trained rats	32450
greater ankle extension	32477
the stand test	32508
The effects of OEG transplantation and training on weight-support ability	32523
The effects	32523
OEG transplantation and training on weight-support ability	32538
OEG transplantation and training	32538
weight-support ability	32574
a part of the evaluation of locomotor ability	32614
a part	32614
the evaluation of locomotor ability	32624
the evaluation	32624
locomotor ability	32642
Spinal rats	32661
the amount of self-weight support	32683
the amount	32683
self-weight support	32697
collapse between 1 and 4 months regardless of treatment	32724
collapse	32724
between 1 and 4 months	32733
treatment	32770
10 ± 1 % increase	32781
10 ±	32781
1 % increase	32786
1 %	32786
increase	32789
only the OEG-injected groups	32804
between 4 and 7 months	32842
transection -LRB- 6 ± 1 % increase -RRB-	32871
transection	32871
6 ± 1 % increase	32884
6 ±	32884
1 % increase	32888
1 %	32888
increase	32891
Step training	32902
standing ability	32940
any group	32960
We	32971
changes	32988
ankle extension	32999
standing	33022
an evaluation of weight-support ability -LRB- Timoszyk et al. , 2002 -RRB-	33034
an evaluation	33034
weight-support ability -LRB- Timoszyk et al. , 2002 -RRB-	33051
weight-support ability	33051
Timoszyk	33075
et al. , 2002	33084
et al.	33084
2002	33092
1 and 4 months after transection	33102
1 and 4 months	33102
transection	33123
the mean ankle angles	33136
the treatment groups	33180
any level of weight support -LRB- p > 0.05 for all comparisons -RRB-	33204
any level	33204
weight support -LRB- p > 0.05 for all comparisons -RRB-	33217
weight support	33217
p > 0.05 for all comparisons	33234
p	33234
> 0.05 for all comparisons	33236
>	33236
0.05 for all comparisons	33239
0.05	33239
all comparisons	33248
7 months	33269
OEG-trained rats	33288
greater ankle extension at 0 and 10 % body weight support	33318
greater ankle extension at 0	33318
greater ankle extension	33318
0	33345
10 % body weight support	33351
10 %	33351
body weight support	33355
the other three groups -LRB- Fig. 1I -RRB-	33389
the other three groups	33389
Fig. 1I	33413
10 %	33430
there	33435
no group differences	33446
These results	33468
OEG transplantation and step training together , but not individually	33496
OEG transplantation and step training	33496
ankle extension	33575
the ≈ 10 % body weight load used during step training	33597
the ≈ 10 % body weight load	33597
≈ 10 %	33601
≈	33601
step training	33635
Plantar stepping ability	33650
Plantar	33650
ability	33667
retransection only in OEG-injected rats	33690
retransection only	33690
OEG-injected rats	33712
axon regeneration	33746
locomotor activity	33779
we	33799
the number	33811
plantar steps	33825
media or OEG rats	33852
a complete retransection 0.5 cm rostral to the original lesion	33887
a complete retransection 0.5 cm rostral	33887
the original lesion	33930
We	33951
the number	33965
plantar steps	33979
7 months	34006
those produced after the retransection at 8 months	34020
those	34020
the retransection at 8 months	34041
the retransection	34041
8 months	34062
a positive number	34072
a better stepping performance after retransection	34112
a better stepping performance	34112
retransection	34148
there	34171
no training effect	34181
the number	34203
plantar steps	34217
retransection	34243
we	34258
OEGuntrained and - trained groups	34303
OEGuntrained	34303
- trained groups	34320
the mean number of plantar steps for the media group	34346
the mean number	34346
plantar steps for the media group	34365
plantar steps	34365
the media group	34383
retransection	34420
the OEG group	34435
a considerable improvement -LRB- Fig. 2A -RRB-	34456
a considerable improvement	34456
Fig. 2A	34484
two OEG-injected spinal rats that never stepped before retransection	34506
two OEG-injected spinal rats	34506
retransection	34561
six	34585
nine plantar steps	34592
retransection	34617
The number of plantar steps taken after retransection	34632
The number	34632
plantar steps taken after retransection	34646
plantar steps	34646
retransection	34672
OEG - than mediainjected rats	34715
OEG	34715
mediainjected rats	34725
media , 0.9 ± 0.2 ; OEG , 1.7 ± 0.4 ; p < 0.05	34745
media , 0.9 ± 0.2 ; OEG , 1.7 ± 0.4 ; p <	34745
media	34745
0.9 ± 0.2 ; OEG , 1.7 ± 0.4 ; p <	34752
0.9 ± 0.2	34752
0.9	34752
0.2	34758
OEG , 1.7 ± 0.4	34763
OEG	34763
1.7 ± 0.4	34768
1.7 ±	34768
0.4	34774
p <	34779
p	34779
<	34781
0.05	34783
addition	34793
OEG groups	34803
more consistent step trajectories	34827
retransection	34867
the media groups	34902
PCA -LRB- Fig. 2B -RRB-	34952
PCA	34952
Fig. 2B	34957
There	34967
no training effect	34977
consistency	35008
either the media or OEG groups	35023
the media	35030
OEG groups	35043
retransection	35060
data not shown	35075
data	35075
Stance and trajectory lengths	35092
OEGuntrained rats	35154
retransection	35178
no difference	35201
the media-trained and media-untrained rats -LRB- Fig. 2C -RRB-	35236
the media-trained and media-untrained rats	35236
Fig. 2C	35280
The results from the retransection experiments	35290
The results	35290
the retransection experiments	35307
OEG implantation	35350
axon regeneration	35376
the original transection site	35401
the reestablished connections	35436
the	35436
connections	35454
locomotor performance	35498
the combination of retransection and quipazine injection	35527
the combination	35527
retransection and quipazine injection	35546
parameters	35594
those before retransection -LRB- 5 months -RRB- -LRB- Fig. 1F -RRB-	35624
those	35624
retransection -LRB- 5 months -RRB- -LRB- Fig. 1F -RRB-	35637
retransection -LRB- 5 months -RRB-	35637
retransection	35637
5 months	35652
Fig. 1F	35663
Retransection	35673
the number of plantar steps	35701
the number	35701
plantar steps	35715
any group -LRB- data not shown -RRB-	35732
any group	35732
data not shown	35743
data	35743
consistency	35770
step trajectories -LRB- Fig. 2D -RRB- or step heights evaluated with PCA	35785
step trajectories -LRB- Fig. 2D -RRB-	35785
step trajectories	35785
Fig. 2D	35804
step heights evaluated with PCA	35816
heights evaluated	35821
heights	35821
PCA	35844
retransection	35869
groups	35889
Only the OEG-trained rats	35897
their stance and trajectory lengths	35932
retransection -LRB- Fig. 2E -RRB-	35974
retransection	35974
Fig. 2E	35989
These findings	35999
the improvement in stepping performance with quipazine	36025
the improvement	36025
performance	36053
quipazine	36070
some intraspinal reorganization	36089
axon regeneration	36147
OEG transplantation	36166
the withdrawal reflex threshold	36196
The hindlimb flexion response to mechanical stimulation	36228
The hindlimb flexion response	36228
mechanical stimulation	36261
a spinally organized sensorimotor response -LRB- Zemlan et al. , 1984 -RRB-	36305
a spinally organized sensorimotor response	36305
Zemlan	36349
et al. , 1984	36356
et al.	36356
1984	36364
lesion-induced hyper-reflexia	36379
SCI -LRB- Magladery et al. , 1952 ; Reese et al. , 2006 -RRB-	36437
SCI	36437
Magladery	36442
et al. , 1952 ; Reese et al. , 2006	36452
et al.	36452
1952 ; Reese et al.	36460
1952	36460
Reese et al.	36466
Reese	36466
et al.	36472
2006	36480
we	36487
the von Frey test -LRB- Chaplan et al. , 1994 -RRB-	36495
the von Frey test	36495
Chaplan	36514
et al. , 1994	36522
et al.	36522
1994	36530
the effects	36547
OEG transplantation and long-term step training	36562
the hindlimb withdrawal response	36613
mechanical stimulation	36649
Adult intact rats	36673
a withdrawal threshold of 7.9 ± 1.0 g -LRB- n = 8 -RRB-	36695
a withdrawal threshold	36695
7.9 ± 1.0 g -LRB- n = 8 -RRB-	36721
7.9 ± 1.0 g	36721
7.9 ±	36721
1.0 g	36725
n	36732
8	36735
One month	36739
transection	36755
all four groups of spinal rats	36768
all four groups	36768
spinal rats	36787
stimulation -LRB- Fig. 2F -RRB- -LRB- overall mean , 2.1 ± 0.2 g -RRB-	36822
stimulation -LRB- Fig. 2F -RRB-	36822
stimulation	36822
Fig. 2F	36835
overall mean , 2.1 ± 0.2 g	36845
overall mean	36845
2.1 ± 0.2 g	36859
2.1	36859
0.2 g	36865
we	36882
a training effect	36900
any time point	36921
the OEG groups	36937
mechanical stimulation than the media groups	36975
mechanical stimulation	36975
the media groups	37003
7 months -LRB- Fig. 2F -RRB-	37023
7 months	37023
Fig. 2F	37033
We	37043
the withdrawal threshold	37060
retransection	37102
Retransection	37117
this response in media-injected rats	37145
this response	37145
media-injected rats	37162
the improvement	37196
OEG-injected rats	37215
These findings	37234
functional connections across the transection	37263
functional connections	37263
the transection	37293
the reduced hypersensitivity observed in rats with OEG transplantation	37318
the reduced hypersensitivity	37318
rats with OEG transplantation	37359
rats	37359
OEG transplantation	37369
OEG transplantation	37390
axon regeneration	37419
the transection	37444
electrophysiological evidence	37461
We	37491
transcranial electric stimulation	37499
OEG	37553
functional connectivity across the lesion site	37565
functional connectivity	37565
the lesion site	37596
a complete spinal cord transection	37618
the stimulation intensity required to elicit MEPs	37662
the stimulation intensity	37662
MEPs	37707
the type of anesthetic	37723
the type	37723
anesthetic	37735
level of anesthesia	37747
level	37747
anesthesia	37756
location of stimulation and recordings	37768
location	37768
stimulation and recordings	37780
diameter of stimulation	37812
diameter	37812
stimulation	37824
electrodes	37847
we	37859
control experiments	37882
intact rats	37905
Stimulation of both the motor cortex and brainstem of intact rats	37918
Stimulation	37918
both the motor cortex and brainstem	37933
the motor cortex	37938
brainstem	37959
intact rats	37972
n	37985
4	37989
MEP	38014
the MG and TA muscles	38033
the MG	38033
TA muscles	38044
acute spinal cord transection	38078
MEPs detected inMGand TA	38125
MEPs	38125
inMGand TA	38139
the spinal cord	38174
MEPs	38205
longer latencies	38214
pharmacological blockage of excitatory neurotransmitters	38257
pharmacological blockage	38257
excitatory neurotransmitters	38285
intact controls -LRB- Protas et al. , 2008 -RRB-	38317
intact controls	38317
Protas	38334
et al. , 2008	38341
et al.	38341
2008	38349
potentials	38379
latencies	38395
1 ms	38417
neural transmission	38454
Typical MEPs from intact rats	38475
Typical MEPs	38475
intact rats	38493
2 -- 10 mV with a latency of ≈ 8 ms -LRB- Fig. 3A , G -RRB-	38510
2	38510
10 mV with a latency of ≈ 8 ms -LRB- Fig. 3A , G -RRB-	38512
10 mV	38512
a latency of ≈ 8 ms -LRB- Fig. 3A , G -RRB-	38523
a latency	38523
≈ 8 ms -LRB- Fig. 3A , G -RRB-	38536
≈ 8 ms	38536
Fig. 3A , G	38543
Fig. 3A	38543
G	38551
stronger stimulation intensities	38560
MEPamplitudes	38594
the latencies	38627
data not shown	38658
data	38658
The recordings at 1 month after lesion	38675
The recordings	38675
1 month after lesion	38693
1 month	38693
lesion	38707
the spinal cord transections	38752
Fig. 3A	38796
No media-injected rats	38806
stimulation	38842
site	38864
any time point	38872
Four months	38888
transection	38906
we	38919
MEPs	38931
long latencies and small amplitudes	38941
long latencies	38941
small amplitudes	38960
15 % -LRB- motor cortex , n = 1 of 22 ; brainstem , n = 3 of 22 -RRB-	38980
15 %	38980
motor cortex , n = 1 of 22 ; brainstem , n = 3 of 22	38985
motor cortex	38985
n = 1 of 22 ; brainstem , n = 3 of 22	38999
n = 1 of 22	38999
n = 1	38999
n	38999
1	39003
22	39008
brainstem , n = 3 of 22	39012
brainstem	39012
n = 3 of 22	39023
n = 3	39023
n	39023
3	39027
22	39032
OEGinjected rats -LRB- Fig. 3B , G -RRB-	39039
OEGinjected rats	39039
Fig. 3B , G	39057
Fig. 3B	39057
G	39065
More OEG-injected rats	39069
MEPs	39102
the mean latency	39108
the amplitude	39142
7 than 4 months	39170
transection -LRB- Fig. 3B , G -RRB-	39192
transection	39192
Fig. 3B , G	39205
Fig. 3B	39205
G	39213
a total	39232
70 % -LRB- motor cortex , 5 of 20 ; brainstem , 12 of 20 -RRB-	39243
70 %	39243
motor cortex , 5 of 20 ; brainstem , 12 of 20	39248
motor cortex	39248
5 of 20 ; brainstem , 12 of 20	39262
5 of 20	39262
5	39262
20	39267
brainstem , 12 of 20	39271
brainstem	39271
12 of 20	39282
12	39282
20	39288
the OEG-injected rats	39295
brainstem stimulation	39346
7 months -LRB- Fig. 3B -RRB-	39371
7 months	39371
Fig. 3B	39381
Brainstem stimulation	39391
relatively stronger MEPs , i.e. , shorter latencies and larger amplitudes ,	39422
relatively stronger MEPs	39422
i.e. , shorter latencies and larger amplitudes	39448
i.e.	39448
shorter latencies	39454
larger amplitudes	39476
cortical stimulation -LRB- Fig. 3G -RRB-	39500
cortical stimulation	39500
Fig. 3G	39522
contrast to intact rats	39535
contrast	39535
intact rats	39547
theMEPamplitudes recorded from OEG-injected rats	39560
theMEPamplitudes	39560
OEG-injected rats	39591
increased stimulation intensity -LRB- data not shown -RRB-	39644
increased stimulation intensity	39644
data not shown	39677
data	39677
addition	39697
MEP latencies and amplitudes	39707
OEG	39778
intact rats -LRB- Fig. 3G -RRB-	39787
intact rats	39787
Fig. 3G	39800
15 % -LRB- 3 of 20 -RRB- of OEG-injected rats	39825
15 % -LRB- 3 of 20 -RRB-	39825
15 %	39825
3 of 20	39830
OEG-injected rats	39842
MEPs	39870
latencies	39880
those in intact rats , i.e. , ≈ 8 ms ,	39913
those in intact rats , i.e.	39913
those	39913
intact rats	39922
8 ms	39942
response	39951
either motor cortex or brainstem stimulation	39963
motor cortex	39970
brainstem stimulation	39986
7 months after transection	40011
7 months	40011
transection	40026
Long-term step training	40039
MEP occurrence	40081
50 % -LRB- OEGuntrained , 7 of 14 ; OEG-trained , 7 of 14 -RRB-	40104
50 %	40104
OEGuntrained , 7 of 14 ; OEG-trained , 7 of 14	40109
OEGuntrained	40109
7 of 14 ; OEG-trained , 7 of 14	40123
7 of 14	40123
7	40123
14	40128
OEG-trained , 7 of 14	40132
OEG-trained	40132
7 of 14	40145
7	40145
14	40150
the rats with MEPs	40157
the rats	40157
MEPs	40171
each OEG group	40184
The mean MEP amplitude	40200
the OEG-trained than - untrained group despite no differences	40247
the OEG-trained	40247
untrained group despite no differences	40269
untrained group	40269
no differences	40293
the mean latency between groups -LRB- Fig. 3C -RRB-	40311
the mean latency	40311
groups -LRB- Fig. 3C -RRB-	40336
groups	40336
Fig. 3C	40344
fresh muscle weight	40362
bilateral medial gastrocnemius	40385
tibialis anterior	40417
soleus	40436
extensor digitorum longus	40448
postmortem	40483
OEG-untrained and trained groups -LRB- data not shown -RRB-	40517
OEG-untrained and trained groups	40517
data not shown	40551
data	40551
the higher MEP amplitude in OEG-trained rats	40568
the higher MEP amplitude	40568
OEG-trained rats	40596
changes in the spinal cord reorganization	40639
changes	40639
the spinal cord reorganization	40650
increased muscle mass from training	40693
increased muscle mass	40693
training	40720
The number	40730
muscles with MEPs in response to either cortical or brainstem stimulation	40744
muscles	40744
MEPs in response to either cortical or brainstem stimulation	40757
MEPs	40757
response to either cortical or brainstem stimulation	40765
response	40765
either cortical or brainstem stimulation	40777
cortical	40784
brainstem stimulation	40796
each rat	40828
7 months -LRB- Fig. 3D -RRB-	40840
7 months	40840
Fig. 3D	40850
Seventy-percent -LRB- 11 of 14 -RRB- of OEG-injected spinal rats	40860
Seventy-percent -LRB- 11 of 14 -RRB-	40860
Seventy-percent	40860
11 of 14	40877
11	40877
14	40883
OEG-injected spinal rats	40890
responses in two or more muscles	40919
responses	40919
two or more muscles	40932
21 % -LRB- 3 of 14 -RRB- of rats	40957
21 % -LRB- 3 of 14 -RRB-	40957
21 %	40957
3 of 14	40962
rats	40974
responses in all four muscles tested	40983
responses	40983
all four muscles tested	40996
all four muscles	40996
More MEPs	41021
the MG than TA	41048
the MG	41048
TA	41060
all stimulation intensities in response	41066
all stimulation intensities	41066
response	41097
both brainstem and cortical stimulation -LRB- Fig. 3E -RRB-	41109
both brainstem and cortical stimulation	41109
Fig. 3E	41150
stimulation intensity	41169
MEP amplitude	41214
more muscles	41229
higher stimulation intensities	41262
i.e.	41294
TA	41305
MG	41312
MEPs	41325
the higher stimulation intensities -LRB- Fig. 3E -RRB-	41333
the higher stimulation intensities	41333
Fig. 3E	41369
Many of these muscles	41379
Many	41379
these muscles	41387
inconsistent responses	41411
the same stimulation intensity	41437
not all stimulation pulses in a series	41477
not all stimulation pulses	41477
a series	41507
an MEP	41525
incidence of response	41533
incidence	41533
response	41546
10 to 100 %	41567
the stimulation intensity	41583
the incidence of response -LRB- data not shown -RRB-	41637
the incidence	41637
response -LRB- data not shown -RRB-	41654
response	41654
data not shown	41664
data	41664
consecutive stimulations at a single intensity	41691
consecutive stimulations	41691
a single intensity	41719
potentials	41758
different latencies and amplitudes	41774
30 % of the rats -LRB- 6 of 14 -RRB- -LRB- Fig. 3F -RRB-	41812
30 %	41812
the rats -LRB- 6 of 14 -RRB- -LRB- Fig. 3F -RRB-	41819
the rats -LRB- 6 of 14 -RRB-	41819
the rats	41819
6 of 14	41829
Fig. 3F	41839
a phenomenon	41849
intact rats	41878
This variation	41891
different synaptic reconnections	41920
response	41971
a specific stimulus	41983
the functional reconnections of descending pathways	42012
the functional reconnections	42012
descending pathways	42044
every stimulation	42101
Eight months	42120
injury	42139
we	42147
transcranial stimulation	42160
7 media-injected and 10 OEG-injected rats	42188
3 and 5 d	42273
retransection	42289
these MEP signals	42324
physiological reconnections	42352
the original transection site	42387
The MEPs	42418
retransection in every rat	42448
retransection	42448
every rat	42465
detectable	42480
potentials	42498
retransection -LRB- Fig. 3A , bottom trace , retx -RRB-	42516
retransection	42516
Fig. 3A	42531
bottom trace , retx	42540
additional evidence	42571
OEG	42596
electrophysiologically viable reconnections	42609
the original lesion	42660
OEG transplantation	42681
axon regeneration	42713
the transection	42738
anatomical evidence Regeneration	42755
brainstem and cervical spinal cord axons	42802
the extent of axon regeneration	42856
the extent	42856
axon regeneration	42870
the transection	42895
we	42912
WGA -- HRP into the lower thoracic cords of 3 intact and 22 spinal rats	42924
WGA	42924
HRP into the lower thoracic cords of 3	42928
HRP	42928
the lower thoracic cords of 3	42937
the lower thoracic cords	42937
3	42965
22 spinal rats	42978
8 months	42993
transection	43008
media-untrained	43021
n = 5 , media-trained ; n = 7 , OEG-untrained ; n = 5 , OEG-trained ; n = 5	43038
n = 5 , media-trained	43038
n	43038
5 , media-trained	43042
5	43042
n = 7 , OEG-untrained	43060
n	43060
7 , OEG-untrained	43064
7	43064
n = 5 , OEG-trained	43082
n	43082
5 , OEG-trained	43086
5	43086
n = 5	43102
n	43102
5	43106
None of the spinal rats	43110
None	43110
the spinal rats	43118
additional analyses	43146
leakage of WGA -- HRP into the lesion core	43170
leakage of WGA	43170
leakage	43170
WGA	43181
HRP into the lesion core	43185
HRP	43185
the lesion core	43194
the rostral stump -LRB- supplemental Fig. 1C , available at www	43213
the rostral stump	43213
supplemental Fig. 1C	43232
www	43267
jneurosci.org	43272
supplemental material	43289
supplemental	43289
material	43302
intact rats	43316
we	43329
WGA-positive somata	43341
the motor cortex	43364
supplemental Fig. 1A , available at www.jneurosci.org as supplemental material	43382
supplemental Fig. 1A	43382
www.jneurosci.org	43417
supplemental material	43438
red nucleus	43462
locus coeruleus	43475
vestibular nucleus	43492
reticular formation	43512
raphe nucleus	43533
cervical enlargement -LRB- Fig. 4A -RRB-	43552
cervical enlargement	43552
Fig. 4A	43574
an objective densitometry method	43593
the number	43627
WGA-positive somata	43641
the brainstem and rostral spinal cord of both media and OEG groups	43664
the brainstem and rostral spinal cord	43664
both media and OEG groups	43705
knowledge of the experimental status of each rat -LRB- Fig. 4B , C -RRB-	43754
knowledge	43754
the experimental status of each rat -LRB- Fig. 4B , C -RRB-	43767
the experimental status	43767
each rat -LRB- Fig. 4B , C -RRB-	43794
each rat	43794
Fig. 4B , C	43804
Fig. 4B	43804
C	43812
Immunoreactive cells	43816
WGA-positive only	43856
their optical density	43879
at least 5 %	43905
the maximum background level	43930
each section	43973
supplemental Fig. 1D	43987
G , available at www.jneurosci.org as supplemental material	44008
G	44008
www.jneurosci.org	44024
supplemental material	44045
The WGA-labeled neurons in spinal rats	44069
The WGA-labeled neurons	44069
spinal rats	44096
location , size , and shape	44124
those found in intact rats -LRB- Fig. 4A -- C -RRB-	44153
those	44153
intact rats -LRB- Fig. 4A -- C -RRB-	44168
intact rats	44168
Fig. 4A -- C	44181
Fig. 4A	44181
C	44189
We	44193
more WGA-positive somata	44202
the red nucleus , locus coeruleus , vestibular nucleus , and raphe nucleus	44230
the red nucleus	44230
locus coeruleus	44247
vestibular nucleus	44264
raphe nucleus	44288
the reticular formation of OEG -	44313
the reticular formation	44313
OEG	44340
media-injected rats -LRB- Table 1 , Fig. 4D -RRB-	44350
media-injected rats	44350
Table 1	44371
Fig. 4D	44380
There	44390
no WGA-positive somata in the primary motor cortex of any spinal rat	44401
no WGA-positive somata	44401
the primary motor cortex of any spinal rat	44427
the primary motor cortex	44427
any spinal rat	44455
supplemental Fig. 1B	44471
www	44506
jneurosci.org	44511
supplemental material	44528
supplemental	44528
material	44541
We	44552
more WGA-positive somata	44564
laminae VII , VIII , and X of the cervical enlargement in OEG -	44592
laminae VII , VIII	44592
laminae VII	44592
VIII	44605
X of the cervical enlargement in OEG	44615
X	44615
the cervical enlargement in OEG	44620
the cervical enlargement	44620
OEG	44648
media-injected rats -LRB- Fig. 4D -RRB-	44658
media-injected rats	44658
Fig. 4D	44679
These retrogradely labeled cell bodies	44689
shape and 20	44750
shape	44750
20	44760
30 min diameter	44763
processes , features	44795
processes	44795
features	44806
long propriospinal neurons that contact	44826
long propriospinal neurons	44826
Mene ' trey et al. , 1985	44896
Mene ' trey	44896
et al.	44906
1985	44914
we	44926
the number of retrogradely	44943
the number	44943
retrogradely	44957
somata in media-injected controls	44978
somata	44978
media-injected controls	44988
spontaneous axon regeneration or nonspecific uptake of the tracer	45032
spontaneous axon regeneration or nonspecific uptake	45032
the tracer	45087
this issue	45110
we	45122
WGA -- HRP	45134
WGA	45134
HRP	45138
three mediainjected spinal rats 1 month	45147
three mediainjected spinal rats	45147
1 month	45179
transection as an additional control	45193
transection	45193
an additional control	45208
We	45231
WGA-labeled somata in all three media rats	45243
WGA-labeled somata	45243
all three media rats	45265
1monththat	45301
regeneration -LRB- Table 1 , Fig. 4D -RRB-	45340
regeneration	45340
Table 1	45354
Fig. 4D	45363
the average number of labeled cells in the brainstem or cervical spinal cord	45383
the average number	45383
labeled cells in the brainstem or cervical spinal cord	45405
labeled cells	45405
the brainstem or cervical spinal cord	45422
the brainstem	45422
cervical spinal cord	45439
media rats	45497
1 or 8 months	45514
These results	45541
a consistent level of spurious WGA-labeled somata in spinal rats	45563
a consistent level	45563
spurious WGA-labeled somata in spinal rats	45585
spurious WGA-labeled somata	45585
spinal rats	45616
spontaneous regeneration -LRB- Fig. 4D -RRB-	45640
spontaneous regeneration	45640
Fig. 4D	45666
detection	45685
more	45698
cells	45724
the brainstem -LRB- excluding the reticular formation -RRB-	45733
the brainstem	45733
the reticular formation	45758
spinal cord of OEG	45787
spinal cord	45787
OEG	45802
media-injected long-term spinal rats	45812
our behavioral and electrophysiological evidence	45868
OEG transplantation	45922
axon regeneration	45951
the transection	45976
Raphespinal regeneration	45993
OEG transplantation	46034
raphespinal regeneration	46063
we	46089
the presence of serotonergic axons spanning the lesion	46101
the presence	46101
serotonergic axons spanning the lesion	46117
serotonergic axons	46117
the lesion	46145
We	46157
examples	46166
axons	46178
both GFAP borders and the GFAP-negative lesion core only	46206
both GFAP borders	46206
the GFAP-negative lesion core only	46228
OEG-injected rats	46266
Fig. 5A	46285
We	46295
5-HT axons that sprouted within the lesion core in both media	46312
5-HT axons	46312
the lesion core	46344
media	46368
OEG-injected rats -LRB- Fig. 5B , C -RRB-	46379
OEG-injected rats	46379
Fig. 5B , C	46398
Fig. 5B	46398
C	46406
more found in OEG - than media-injected rats -LRB- Fig. 5D -RRB-	46415
more	46415
OEG	46429
media-injected rats -LRB- Fig. 5D -RRB-	46439
media-injected rats	46439
Fig. 5D	46460
these 5-HT axons in the lesion core	46491
these 5-HT axons	46491
the lesion core	46511
the raphe nucleus	46543
spinal cord interneurons	46564
Newton and Hamill , 1988 ; Takeoka et al. , 2009	46590
Newton and Hamill	46590
1988 ; Takeoka et al.	46609
1988	46609
Takeoka et al.	46615
Takeoka	46615
et al.	46623
2009	46631
we	46638
the original lesion core	46650
spinal rats	46693
few 5-HT axons	46715
This finding	46731
the 5-HT axons that sprouted into the lesion core	46758
the 5-HT axons	46758
the lesion core	46792
raphespinal neurons rather than intraspinal 5-HT neurons	46834
raphespinal neurons	46834
intraspinal 5-HT neurons	46866
We	46892
the 5-HT axons	46911
the caudal stump	46929
they	46954
the rare serotonergic spinal neurons	46980
raphespinal regeneration -LRB- Takeoka et al. , 2009 -RRB-	47050
raphespinal regeneration	47050
Takeoka et al. , 2009	47076
Takeoka et al.	47076
2009	47092
axon regeneration GAP43	47109
somata and growing axons	47161
most neurons	47189
development -LRB- Jacobson et al. , 1986 ; Goslin et al. , 1990 -RRB-	47209
development	47209
Jacobson	47222
et al. , 1986 ; Goslin et al. , 1990	47231
et al.	47231
1986 ; Goslin et al.	47239
1986	47239
Goslin et al.	47245
Goslin	47245
et al.	47252
1990	47260
axotomy	47273
adult neurons	47282
retinal ganglion cells , dorsal root ganglion , and spinal neurons	47305
retinal ganglion cells	47305
dorsal root ganglion	47329
spinal neurons	47355
GAP43	47391
their somata	47400
Doster et al. , 1991 ; Schreyer and Skene , 1991 ; Siebert et al. , 2010	47414
Doster	47414
et al. , 1991 ; Schreyer and Skene , 1991 ; Siebert et al. , 2010	47421
et al. , 1991	47421
et al.	47421
1991	47429
Schreyer and Skene , 1991	47435
Schreyer and Skene	47435
1991	47455
Siebert et al. , 2010	47461
Siebert	47461
et al. , 2010	47469
et al.	47469
2010	47477
GAP43	47492
a marker of recent axotomy	47501
a marker	47501
recent axotomy	47513
we	47529
any ascending axons that regenerated across the original transection	47550
any	47550
axons that regenerated across the original transection	47564
axons	47564
the original transection	47594
GAP43 in their cell bodies	47648
GAP43	47648
their cell bodies	47657
retransection 0.5 cm rostral	47681
the initial site -LRB- diagram in Fig. 5E -RRB-	47713
the initial site	47713
diagram in Fig. 5E	47731
diagram	47731
Fig. 5E	47742
we	47759
spinal rats	47771
a retransection	47804
no labeled somata but numerous GAP43-positive axons within the lesion core	47830
no labeled somata	47830
numerous GAP43-positive axons within the lesion core	47852
numerous GAP43-positive axons	47852
the lesion core	47889
fibers	47906
the meninges	47929
blood vessels	47958
axons	47985
the dorsal and ventral roots	47998
the dorsal	47998
ventral roots	48013
data not shown	48028
data	48028
a pattern	48048
peripherally derived noradrenergic axons -LRB- Takeoka et al. , 2010 -RRB-	48069
peripherally derived noradrenergic axons	48069
Takeoka	48111
et al. , 2010	48119
et al.	48119
2010	48127
retransection , axotomized GAP43-positive	48140
retransection	48140
somata	48181
the rostral stump between the initial and retransection sites	48195
the rostral stump	48195
the initial and retransection sites	48221
both media and OEG groups -LRB- diagram in Fig. 5E -RRB-	48260
both media and OEG groups	48260
diagram in Fig. 5E	48287
diagram	48287
Fig. 5E	48298
contrast , sparse GAP43 - labeled	48311
contrast , sparse GAP43 -	48311
contrast	48311
sparse GAP43	48321
somata	48343
the caudal stump	48359
the	48379
cords	48396
lamina V with a few cells in lamina X -LRB- Fig. 5F , G -RRB-	48416
lamina V	48416
a few cells in lamina X -LRB- Fig. 5F , G -RRB-	48430
a few cells	48430
lamina X -LRB- Fig. 5F , G -RRB-	48445
lamina X	48445
Fig. 5F , G	48455
Fig. 5F	48455
G	48463
These GAP43-labeled somata caudal to the initial transection likely	48467
These GAP43-labeled somata caudal	48467
the initial transection likely	48504
the initial transection	48504
neurons with axons that had regenerated past the original lesion	48545
neurons	48545
axons that had regenerated past the original lesion	48558
axons	48558
the original lesion	48590
the retransection	48655
This interpretation of upregulated somatic GAP43	48674
This interpretation	48674
somatic GAP43	48709
the caudal stump	48740
spinal cord injury studies	48760
an initial complete transection	48796
a lengthy period for axon regeneration	48841
a lengthy period	48841
axon regeneration	48862
a complete spinal cord retransection rostral to the original injury	48890
a complete spinal cord retransection rostral	48890
the original injury	48938
then perfusions performed within 14 d after retransection	48963
then perfusions	48963
14 d	48996
retransection	49007
We	49022
GAP43-labeled cell bodies	49036
the caudal stump	49065
more	49092
immunopositive somata in OEG	49104
immunopositive somata	49104
OEG	49129
media groups -LRB- Fig. 5H -RRB-	49138
media groups	49138
Fig. 5H	49152
These results	49162
OEG implantation	49189
regeneration of ascending axons	49215
regeneration	49215
axons	49241
a limited amount of spontaneous regeneration	49256
a limited amount	49256
spontaneous regeneration	49276
longterm , media-injected rats	49314
OEG	49345
tissue and neurons	49358
the lesion We measured the volume of the GFAPnegative lesion core	49389
the lesion	49389
We	49400
the volume of the GFAPnegative lesion core	49412
the volume	49412
the GFAPnegative lesion core	49426
cavitations	49470
OEG	49503
tissue degeneration	49517
the injury	49543
The average volume of the injury site	49555
The average volume	49555
the injury site	49577
larger in media	49597
larger	49597
media	49607
OEGinjected rats -LRB- Fig. 6A , B -RRB- ,	49619
OEGinjected rats	49619
Fig. 6A , B	49637
Fig. 6A	49637
B	49645
our previous studies	49673
Kubasak	49695
et al. , 2008 ; Mun˜oz - Quiles et al. , 2009	49703
et al.	49703
2008 ; Mun˜oz - Quiles et al.	49711
2008 ; Mun˜oz	49711
2008	49711
Mun˜oz	49717
Quiles et al.	49724
Quiles	49724
et al.	49731
2009	49739
We	49746
the rostral and caudal stumps with anti-GFAP and spinal cord neurons	49760
the rostral	49760
caudal stumps with anti-GFAP and spinal cord neurons	49776
caudal stumps	49776
anti-GFAP and spinal cord neurons	49795
the extent of injury-induced neuronal degeneration -LRB- Fig. 6C -RRB-	49856
the extent	49856
injury-induced neuronal degeneration -LRB- Fig. 6C -RRB-	49870
injury-induced neuronal degeneration	49870
Fig. 6C	49908
We	49918
NeuN-labeled cell bodies	49927
the GFAPnegative lesion core	49976
Fig. 6D	50033
media-injected -LRB- Fig. 6C -RRB- spinal cords	50047
Fig. 6C	50063
The distance	50086
the most proximal NeuN-labeled neuron and the GFAP-negative lesion core	50107
the most proximal NeuN-labeled neuron	50107
the GFAP-negative lesion core	50149
the rostral	50194
the caudal stump	50214
all spinal rats	50234
media : rostral	50251
media	50251
rostral	50258
0.67 ± 0.06 cm	50267
0.67	50267
0.06 cm	50272
caudal	50283
1.31 ± 0.11 cm	50291
1.31	50291
0.11 cm	50296
OEG : rostral , 0.25 ± 0.07 cm and caudal , 0.48 ± 0.06 cm	50305
OEG	50305
rostral , 0.25 ± 0.07 cm and caudal , 0.48 ± 0.06 cm	50310
rostral	50310
0.25 ± 0.07 cm and caudal , 0.48 ± 0.06 cm	50319
0.25 ± 0.07 cm	50319
0.25	50319
0.07 cm	50324
caudal , 0.48 ± 0.06 cm	50336
caudal	50336
0.48 ± 0.06 cm	50344
0.48	50344
0.06 cm	50349
p < 0.05	50358
p <	50358
p	50358
0.05	50361
a result	50368
more neurons in the rostral stump	50397
more neurons	50397
the rostral stump	50413
the caudal stump	50454
the average GFAP-positive non-neuronal zone -LRB- Fig. 6E -RRB-	50490
the average GFAP-positive non-neuronal zone	50490
Fig. 6E	50535
the total distance between neurons	50548
the total distance	50548
neurons	50575
the rostral	50594
caudal stumps -LRB- Fig. 6F -RRB-	50610
caudal stumps	50610
Fig. 6F	50625
OEG	50650
media groups	50659
These results	50673
thatOEGtransplantation	50695
neuronal survival	50727
a complete transection	50751
combination with a smaller lesion volume	50797
combination	50797
a smaller lesion volume	50814
regenerating axons	50839
a shorter distance	50869
project	50891
a neuronal target on the opposite side of the transection in OEG	50902
a neuronal target	50902
the opposite side of the transection in OEG	50923
the opposite side	50923
the transection in OEG	50944
the transection	50944
OEG	50963
media-injected rats	50973
p75-NGFR-positive OEG	50994
8 months	51024
transplantation OEG	51039
Hoechst -LRB- Ramo ' n-Cueto et al. , 2000 -RRB-	51080
Hoechst	51080
Ramo ' n-Cueto et al. , 2000	51089
Ramo ' n-Cueto et al.	51089
Ramo ' n-Cueto	51089
Ramo '	51089
2000	51111
8 months	51123
we	51139
anti-p75-NGFR	51147
immunolabeled OEG	51173
Hoechst-labeled nuclei	51196
the transection -LRB- Pearse et al. , 2007 ; Lankford et al. , 2008 -RRB-	51231
the transection	51231
Pearse	51248
et al. , 2007 ; Lankford et al. , 2008	51255
et al.	51255
2007 ; Lankford et al.	51263
2007	51263
Lankford et al.	51269
Lankford	51269
et al.	51278
2008	51286
We	51293
a number of p75-NGFR - and Hoechst-labeled cells	51305
a number	51305
p75-NGFR - and Hoechst-labeled cells	51317
the spinal stumps	51360
Fig. 7A , B	51379
Fig. 7A	51379
B	51387
the lesion core	51394
Fig. 7C	51411
These putative OEG	51421
each other	51487
form tubular structures -LRB- Fig. 7B , C -RRB-	51503
form tubular structures	51503
Fig. 7B , C	51528
Fig. 7B	51528
C	51536
transplantation in vivo -LRB- Sasaki et al. , 2004 -RRB-	51557
transplantation	51557
vivo	51576
Sasaki	51582
et al. , 2004	51589
et al.	51589
2004	51597
OEG	51604
smooth oval nuclei -LRB- Field et al. , 2003 ; Smithson et al. , 2010 -RRB-	51634
smooth oval nuclei	51634
Field	51654
et al. , 2003 ; Smithson et al. , 2010	51660
et al.	51660
2003 ; Smithson et al.	51668
2003	51668
Smithson et al.	51674
Smithson	51674
et al.	51683
2010	51691
a feature	51698
them	51727
macrophages	51737
activated microglia -LRB- Nguyen et al. , 1994 ; Raivich et al. , 1998 -RRB-	51752
activated microglia	51752
Nguyen	51773
et al. , 1994 ; Raivich et al. , 1998	51780
et al.	51780
1994 ; Raivich et al.	51788
1994	51788
Raivich et al.	51794
Raivich	51794
et al.	51802
1998	51810
addition to OEG	51820
addition	51820
OEG	51832
endogenous Schwann cells that migrate into the core of the injury	51837
endogenous Schwann cells	51837
the core of the injury	51880
the core	51880
the injury	51892
p75-NGFR	51916
OEG	51963
p75-NGFR/Hoechst-labeled cells in the spinal cord stumps	51989
p75-NGFR/Hoechst-labeled cells	51989
the spinal cord stumps	52023
OEG	52063
Schwann cells	52075
spinal cord areas	52111
an astrocytic scar -LRB- Lakatos et al. , 2000 ; Raisman and Li , 2007 -RRB-	52141
an astrocytic scar	52141
Lakatos	52161
et al. , 2000 ; Raisman and Li , 2007	52169
et al.	52169
2000 ; Raisman and Li	52177
2000	52177
Raisman and Li	52183
2007	52199
Other Hoechst-labeled nuclei without p75-NGFR expression	52206
Other Hoechst-labeled nuclei	52206
p75-NGFR expression	52243
the portion	52280
transplanted OEG	52295
p75-NGFR expression or a redistribution of Hoechst	52330
p75-NGFR expression	52330
a redistribution of Hoechst	52353
a redistribution	52353
Hoechst	52373
host cells -LRB- Iwashita et al. , 2000 -RRB-	52388
host cells	52388
Iwashita	52400
et al. , 2000	52409
et al.	52409
2000	52417
We	52424
ED1-positive macrophages	52448
Hoechst-labeled nuclei	52490
OEG-injected rats -LRB- Fig. 7D -RRB-	52516
OEG-injected rats	52516
Fig. 7D	52535
the distribution of ED1-positive macrophages around the lesion core	52553
the distribution	52553
ED1-positive macrophages around the lesion core	52573
ED1-positive macrophages	52573
the lesion core	52605
similar in media - and OEG-injected spinal cords	52625
media	52636
8 months	52676
transection	52691
Hoechst labeling	52713
the full extent of OEG survival	52753
the full extent	52753
OEG survival	52772
doublelabeled p75-NGFR and Hoechst profiles	52786
OEG	52843
8 months	52859
implantation	52874
Discussion OEGfacilitated regeneration	52889
the lesion and reorganization of neural circuits	52935
the lesion and reorganization	52935
neural circuits	52968
the caudal stump	52987
Behavioral and electrophysiological data	53005
complete spinal cord retransection experiments 8 months after the initial lesion	53052
complete spinal cord retransection experiments	53052
8 months	53099
the initial lesion	53114
the regenerating axons in OEG-injected rats	53164
the regenerating axons	53164
OEG-injected rats	53190
retransection	53231
no MEPs	53246
the decreased hypersensitivity to mechanical stimulation	53264
the decreased hypersensitivity	53264
mechanical stimulation	53298
some OEG-injected rats	53339
their locomotor performance	53384
OEG transplantation combined with step training	53413
OEG transplantation	53413
step training	53447
the reorganization	53473
lumbosacral circuits	53495
quipazine	53559
the weight-supporting ability of adult spinal rats	53576
the weight-supporting ability	53576
adult spinal rats	53609
OEG transplantation	53628
neurons	53663
the volume	53683
the lesion core	53697
changes that would facilitate axon regeneration across the transection	53714
changes	53714
axon regeneration	53744
the transection	53769
These changes	53786
the combination	53808
spinal circuit reorganization and axon regeneration	53827
sensorimotor function -LRB- Fig. 8 -RRB-	53919
sensorimotor function	53919
Fig. 8	53942
Evidence of caudal stump reorganization in the recovery of motor function	53951
Evidence	53951
caudal stump reorganization in the recovery of motor function	53963
caudal stump reorganization	53963
the recovery of motor function	53994
the recovery	53994
motor function	54010
Our previous study	54025
Kubasak	54045
et al. , 2008	54053
et al.	54053
2008	54061
step training	54081
locomotor function of mediainjected adult rats	54117
locomotor function	54117
mediainjected adult rats	54139
OEG transplantation	54168
hindlimb locomotion , findings confirmed by the current results	54203
hindlimb locomotion	54203
findings confirmed by the current results	54224
findings	54224
the current results	54246
Kubasak et al. -LRB- 2008 -RRB-	54267
Kubasak et al.	54267
Kubasak	54267
et al.	54275
2008	54283
OEG-trained rats	54306
their stepping ability	54332
time	54360
the present study , improvement of plantar	54377
the present study	54377
improvement of plantar	54396
improvement	54396
plantar	54411
This early improvement likely	54445
This early improvement	54445
reorganization	54486
the caudal stump	54508
there	54533
no electrophysiological evidence of regeneration	54543
no electrophysiological evidence	54543
regeneration	54579
1	54595
month	54597
transection	54609
plantar	54631
OEG groups and longer stance and step trajectories	54651
OEG groups	54651
longer stance and step trajectories	54666
OEG-untrained rats after retransection	54731
OEG-untrained rats	54731
retransection	54756
OEG transplantation	54783
long-term training	54827
function within the locomotor networks	54864
function	54864
the locomotor networks	54880
One factor that could facilitate locomotion	54904
locomotion	54937
the increased frequency	54951
serotonergic and noradrenergic varicosities	54978
the motor-associated cholinergic neurons	55031
OEG-injected rats -LRB- Takeoka et al. , 2009 , 2010 -RRB-	55075
OEG-injected rats	55075
Takeoka	55094
et al. , 2009 , 2010	55102
et al.	55102
2009	55110
2010	55116
OEG and step training	55137
locomotor performance	55168
pharmacological activation of 5-HT2A receptors	55196
pharmacological activation	55196
5-HT2A receptors	55226
retransection	55252
the improved plantar stepping ability	55280
media	55321
OEG-trained rats	55332
quipazine	55354
the improvement	55365
changes within the caudal stump rather than axonal regeneration	55408
changes	55408
the caudal stump rather than axonal regeneration	55423
the caudal stump	55423
axonal regeneration	55452
Evidence	55473
axon regeneration	55485
the transection Spinal cord retransections	55510
critical evidence	55562
OEG transplantation	55585
regeneration	55644
several OEG-injected rats	55672
the 7 monthly kinematics tests	55732
the 7 monthly kinematics	55732
tests	55757
their stepping performance	55785
retransection	55818
a result	55833
regenerated axons	55861
Fig. 8	55900
Both facilitation and suppression of the spinal circuitry	55909
Both facilitation and suppression	55909
the spinal circuitry	55946
the control	55984
intact locomotion -LRB- Bonnot et al. , 1998 ; Iglesias et al. , 2008 -RRB-	55999
intact locomotion	55999
Bonnot	56018
et al. , 1998 ; Iglesias et al. , 2008	56025
et al.	56025
1998 ; Iglesias et al.	56033
1998	56033
Iglesias et al.	56039
Iglesias	56039
et al.	56048
2008	56056
It	56063
extent to which the regenerated axons are functional	56081
extent	56081
the regenerated axons	56097
the net effect	56141
they	56164
circuits	56199
the classical neurophysiological definition	56211
the sense	56276
they	56291
hindlimb stepping functions	56311
hindlimb	56311
functions	56329
axon regeneration	56353
a net suppressive effect on the locomotor networks	56387
a net suppressive effect	56387
the locomotor networks	56415
the injury-induced hypersensitive hindlimb withdrawal in this study	56442
the injury-induced hypersensitive hindlimb withdrawal	56442
this study	56499
These results	56511
axon regeneration	56551
behavioral consequences	56624
Our electrophysiological results	56670
axons	56717
the transection	56741
functional connections	56766
OEG-injected rats	56792
the process	56815
connections	56847
those in intact rats	56881
those	56881
intact rats	56890
4 months after transection	56906
4 months	56906
transection	56921
we	56934
reconnections	56943
long latencies , features consistent with polysynaptic	56962
long latencies	56962
features consistent with polysynaptic	56978
features	56978
polysynaptic	57003
electrical conduction	57028
We	57051
7 months	57074
MEPs	57093
latencies similar to those of intact rats	57103
latencies	57103
those of intact rats	57124
those	57124
intact rats	57133
The small amplitudes of most MEPs	57146
The small amplitudes	57146
most MEPs	57170
relatively few connections	57191
intact rats	57247
a 100 % frequency of response	57263
a 100 % frequency	57263
response	57283
transcranial stimulation	57295
we	57321
inconsistent responses	57328
OEG-injected rats	57354
weak connections established by regenerating axons	57384
weak connections	57384
regenerating axons	57416
electrophysiological data	57450
retrograde tracing results	57477
retrograde	57477
results	57496
the re-established projections to somatic motor neurons	57517
the re-established projections	57517
somatic motor neurons	57551
example	57603
two OEG-injected rats that responded to cortical stimulation	57612
two OEG-injected rats	57612
cortical stimulation	57652
the retrograde tracer	57692
neither	57719
WGA-labeled somata in the motor cortex	57731
WGA-labeled somata	57731
the motor cortex	57753
Interpretations consistent with these data	57771
Interpretations	57771
these data	57803
corticospinal axons	57823
the rostral stump	57855
interneurons that then crossed the transection	57887
interneurons	57887
the transection	57918
corticospinal axons	57942
the transection site	57970
an interneuron	58005
somatic motor neurons -LRB- Fig. 8 -RRB-	58049
somatic motor neurons	58049
Fig. 8	58072
the brainstem nuclei	58092
connections that were predominantly polysynaptic	58128
connections	58128
this	58182
some OEG-injected rats	58203
relatively few	58230
cells in the brainstem	58266
cells	58266
the brainstem	58275
MEPs	58298
their hindlimb muscles	58320
some regenerated axons	58359
the tracer	58433
Perhaps some regenerating axons	58445
Perhaps some	58445
axons	58471
nonfunctional or aberrant connections that then are later eliminated	58487
nonfunctional or aberrant connections	58487
Bareyre	58557
et al. , 2004 ; Calancie et al. , 2005	58565
et al.	58565
2004 ; Calancie et al.	58573
2004	58573
Calancie et al.	58579
Calancie	58579
et al.	58588
2005	58596
the process of synapse elimination	58618
the process	58618
synapse elimination	58633
development	58660
Additional evidence consistent with axon regeneration in OEG-injected rats	58673
Additional evidence	58673
axon regeneration in OEG-injected rats	58709
axon regeneration	58709
OEG-injected rats	58730
raphespinal axons	58757
the transection and upregulation of GAP43 in somata that likely	58788
the transection and upregulation	58788
GAP43 in somata that likely	58824
GAP43	58824
somata	58833
a response to axotomy	58863
a response	58863
axotomy	58877
retransection	58891
GAP43-positive somata in the caudal stump of OEG-injected rats	58906
GAP43-positive somata	58906
the caudal stump of OEG-injected rats	58931
the caudal stump	58931
OEG-injected rats	58951
lamina V	58995
sensory neurons	59035
Baker and Giesler	59052
1984	59071
Mene ' trey	59077
Basbaum , 1987 ; Villanueva et al. , 1991 ; Ramo ' n-Cueto et al.	59091
Basbaum , 1987	59091
Basbaum	59091
1987	59100
Villanueva et al. , 1991	59106
Villanueva	59106
et al. , 1991	59117
et al.	59117
1991	59125
Ramo ' n-Cueto et al.	59131
Ramo ' n-Cueto	59131
Ramo '	59131
et al.	59145
1998	59153
Detailed sensory testing	59160
this study	59206
it	59232
these axons	59254
functional consequences	59271
there	59305
an inconsistency	59314
the electrophysiological and anatomical results in long-term media-injected rats	59339
the electrophysiological and anatomical results	59339
long-term media-injected rats	59390
some spurious labeling	59430
WGA -- HRP injections	59468
WGA	59468
HRP injections	59472
we	59488
extensive WGA-labeled somata in the red nucleus of two media rats	59500
extensive WGA-labeled somata	59500
the red nucleus of two media rats	59532
the red nucleus	59532
two media rats	59551
8 months	59581
transection	59596
1 month media	59619
Chronic media rats	59643
several GAP43-positive somata in the caudal stump	59671
several GAP43-positive somata	59671
the caudal stump	59704
retransection	59727
we	59750
transections	59808
these results	59836
the possibility	59861
limited spontaneous axon regeneration	59882
long-term spinal rats	59933
Mun˜oz - Quiles et al. -LRB- 2009 -RRB-	59971
Mun˜oz	59971
Quiles et al. -LRB- 2009 -RRB-	59978
Quiles	59978
et al. -LRB- 2009 -RRB-	59985
et al.	59985
2009	59993
the present study	60003
there	60031
no evidence	60041
spontaneous regeneration	60058
functional changes	60098
the combination of retrograde tracer and retransection data	60131
the combination	60131
retrograde tracer and retransection data	60150
the overinterpretation of anatomical evidence of regeneration	60207
the overinterpretation	60207
anatomical evidence of regeneration	60233
anatomical evidence	60233
regeneration	60256
the value of a retransection experiment	60285
the value	60285
a retransection experiment	60298
regenerating axons	60346
Promotion of axon regeneration and beyond The current study	60381
Promotion	60381
axon regeneration and beyond The current study	60394
axon regeneration	60394
beyond The current study	60416
an important question of how OEG promote axon regeneration after injury	60448
an important question	60448
OEG	60477
axon regeneration	60489
injury	60513
Olfactory bulb-derived OEG	60521
inhibitory molecules -LRB- García-Alías et al. , 2004 -RRB-	60559
inhibitory molecules	60559
García-Alías	60581
et al. , 2004	60594
et al.	60594
2004	60602
immune and inflammatory responses	60615
Lo ' pez-Vales et al. , 2004 ; Chuah et al. , 2010	60650
Lo '	60650
pez-Vales et al. , 2004 ; Chuah et al. , 2010	60654
et al. , 2004 ; Chuah et al. , 2010	60664
et al. , 2004	60664
et al.	60664
2004	60672
Chuah et al. , 2010	60678
Chuah	60678
et al. , 2010	60684
et al.	60684
2010	60692
the CNS environment	60718
they	60741
astrocytes	60763
vivo	60795
Franklin	60801
et al. , 1996	60810
et al.	60810
1996	60818
Imaizumi et al. , 1998	60824
Imaizumi	60824
et al. , 1998	60833
et al.	60833
1998	60841
Lakatos et al. , 2000 , 2003	60847
Lakatos	60847
et al. , 2000 , 2003	60855
et al.	60855
2000	60863
2003	60869
Raisman and Li , 2007	60875
Raisman and Li	60875
2007	60891
The present results	60898
additional insight	60933
the possible mechanisms	60957
axon regeneration and the reorganization of spinal neural circuitry	60986
axon regeneration	60986
the reorganization of spinal neural circuitry	61008
the reorganization	61008
spinal neural circuitry	61030
the improvement in motor function	61074
the improvement	61074
motor function	61093
Fig. 8	61120
mature regenerating axons	61157
functionally relevant connections	61192
a complete spinal cord transection	61233
an important future challenge	61269
the extent and balance of axon regeneration	61314
the extent and balance	61314
axon regeneration	61340
functionally useful axon -- target reconnections ,	61368
functionally useful axon	61368
target reconnections	61393
strategies	61428
functional efficacy	61461
